<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke - Bath, PMW - 2017 | Cochrane Library</title> <meta content="Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke - Bath, PMW - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000398.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke - Bath, PMW - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000398.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000398.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke" name="citation_title"/> <meta content="Philip MW Bath" name="citation_author"/> <meta content="University of Nottingham" name="citation_author_institution"/> <meta content="philip.bath@nottingham.ac.uk" name="citation_author_email"/> <meta content="Kailash Krishnan" name="citation_author"/> <meta content="University of Nottingham" name="citation_author_institution"/> <meta content="Jason P Appleton" name="citation_author"/> <meta content="University of Nottingham" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD000398.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/04/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000398.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000398.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000398.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Arginine [*therapeutic use]; Brain Ischemia [drug therapy]; Enzyme Inhibitors [*therapeutic use]; Headache [chemically induced]; Nitric Oxide Donors [adverse effects, *therapeutic use]; Nitric Oxide Synthase [*antagonists &amp; inhibitors]; Nitroglycerin [adverse effects, *therapeutic use]; Quality of Life; Randomized Controlled Trials as Topic; Stroke [*drug therapy, mortality]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000398.pub2&amp;doi=10.1002/14651858.CD000398.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ytRBD0EW";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000398\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000398\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000398.pub2",title:"Nitric oxide donors (nitrates), L\\u2010arginine, or nitric oxide synthase inhibitors for acute stroke",firstPublishedDate:"Apr 21, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Stroke Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000398.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000398.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000398.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000398.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000398.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000398.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000398.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000398.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000398.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000398.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3951 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000398.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-sec-0053"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/appendices#CD000398-sec-0093"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/table_n/CD000398StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/table_n/CD000398StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information#CD000398-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Philip MW Bath</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information#CD000398-cr-0003">Kailash Krishnan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information#CD000398-cr-0004">Jason P Appleton</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information/en#CD000398-sec-0100">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 April 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000398.pub2">https://doi.org/10.1002/14651858.CD000398.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000398-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000398-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000398-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000398-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000398-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000398-abs-0001" lang="en"> <section id="CD000398-sec-0001"> <h3 class="title" id="CD000398-sec-0001">Background</h3> <p>Nitric oxide (NO) has multiple effects that may be beneficial in acute stroke, including lowering blood pressure, and promoting reperfusion and cytoprotection. Some forms of nitric oxide synthase inhibition (NOS‐I) may also be beneficial. However, high concentrations of NO are likely to be toxic to brain tissue. This is an update of a Cochrane review first published in 1998, and last updated in 2002. </p> </section> <section id="CD000398-sec-0002"> <h3 class="title" id="CD000398-sec-0002">Objectives</h3> <p>To assess the safety and efficacy of NO donors, L‐arginine, and NOS‐I in people with acute stroke. </p> </section> <section id="CD000398-sec-0003"> <h3 class="title" id="CD000398-sec-0003">Search methods</h3> <p>We searched the Cochrane Stroke Group Trials Register (last searched 6 February 2017), MEDLINE (1966 to June 2016), Embase (1980 to June 2016), ISI Science Citation Indexes (1981 to June 2016), Stroke Trials Registry (searched June 2016), International Standard Randomised Controlled Trial Number (ISRCTN) (searched June 2016), Clinical Trials registry (searched June 2016), and International Clinical Trials Registry Platform (ICTRP) (searched June 2016). Previously, we had contacted drug companies and researchers in the field. </p> </section> <section id="CD000398-sec-0004"> <h3 class="title" id="CD000398-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing nitric oxide donors, L‐arginine, or NOS‐I versus placebo or open control in people within one week of onset of confirmed stroke. </p> </section> <section id="CD000398-sec-0005"> <h3 class="title" id="CD000398-sec-0005">Data collection and analysis</h3> <p>Two review authors independently applied the inclusion criteria, assessed trial quality and risk of bias, and extracted data. The review authors cross‐checked data and resolved issues through discussion. We obtained published and unpublished data, as available. Data were reported as mean difference (MD) or odds ratio (OR) with 95% confidence intervals (CI). </p> </section> <section id="CD000398-sec-0006"> <h3 class="title" id="CD000398-sec-0006">Main results</h3> <p>We included five completed trials, involving 4197 participants; all tested transdermal glyceryl trinitrate (GTN), an NO donor. The assessed risk of bias was low across the included studies; one study was double‐blind, one open‐label and three were single‐blind. All included studies had blinded outcome assessment. Overall, GTN did not improve the primary outcome of death or dependency at the end of trial (modified Rankin Scale (mRS) &gt; 2, OR 0.97, 95% CI 0.86 to 1.10, 4195 participants, high‐quality evidence). GTN did not improve secondary outcomes, including death (OR 0.78, 95% CI 0.40 to 1.50) and quality of life (MD ‐0.01, 95% CI ‐0.17 to 0.15) at the end of trial overall (high‐quality evidence). Systolic/diastolic blood pressure (BP) was lower in people treated with GTN (MD ‐7.2 mmHg (95% CI ‐8.6 to ‐5.9) and MD ‐3.3 (95% CI ‐4.2 to ‐2.5) respectively) and heart rate was higher (MD 2.0 beats per minute (95% CI 1.1 to 2.9)). Headache was more common in those randomised to GTN (OR 2.37, 95% CI 1.55 to 3.62). We did not find any trials assessing other nitrates, L‐arginine, or NOS‐I. </p> </section> <section id="CD000398-sec-0007"> <h3 class="title" id="CD000398-sec-0007">Authors' conclusions</h3> <p>There is currently insufficient evidence to recommend the use of NO donors, L‐arginine or NOS‐I in acute stroke, and only one drug (GTN) has been assessed. In people with acute stroke, GTN reduces blood pressure, increases heart rate and headache, but does not alter clinical outcome (all based on high‐quality evidence). </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000398-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000398-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000398-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000398-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000398-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000398-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000398-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000398-abs-0003" lang="en"> <h3>Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke </h3> <p><b>Question:</b> Are nitric oxide donors, L‐arginine, or nitric oxide synthase inhibitors safe and effective drugs for use in people soon after they have suffered a stroke? </p> <p><b>Background:</b> Nitric oxide is a key molecule involved in the control of blood pressure, blood flow, and brain activity, both before and during a brain attack (stroke, either due to a blockage or rupture of an artery in the brain). Drugs that produce nitric oxide or control its production may be beneficial in acute stroke. This review looked at trials that tested such drugs in people with a stroke that came on within the last few days. </p> <p><b>Study characteristics:</b> This review is up‐to‐date as of September 2016. We included five trials involving 4197 people; all trials assessed glyceryl trinitrate, a drug that is given as a skin patch and which releases nitric oxide. One study was international, whilst the remainder were studies performed at single centres. Not all trials contributed data to all outcomes. We used both unpublished and published information, where available. We did not find any trials assessing other nitrate drugs, L‐arginine, or nitric oxide synthase inhibitors. </p> <p><b>Key results:</b> Overall, glyceryl trinitrate did not improve the rate of death or dependency compared with those who did not receive glyceryl trinitrate after acute stroke. Glyceryl trinitrate did not improve other outcomes including death and quality of life. Glyceryl trinitrate lowers blood pressure, and increases heart rate and headache in people with acute stroke. </p> <p><b>Quality of the evidence:</b> The key results are based on high‐quality evidence. </p> <p><b>Conclusions:</b> There is currently insufficient evidence to recommend the use of drugs affecting nitric oxide production in acute stroke. Overall, glyceryl trinitrate is inexpensive, lowers blood pressure, increases heart rate and headache, but does not change clinical outcomes in people who have suffered a stroke. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000398-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000398-sec-0088"></div> <h3 class="title" id="CD000398-sec-0089">Implications for practice</h3> <section id="CD000398-sec-0089"> <p>There is currently insufficient evidence to determine the efficacy of NO donors, L‐arginine, or nitric oxide synthase inhibitors in acute stroke, with only RCT evidence available for the NO donor, GTN. In people with acute stroke, transdermal GTN reduces blood pressure, increases heart rate and headache, but does not alter outcome. When administered within six hours, GTN may improve clinical outcomes, a finding that requires confirmation in an independent trial (e.g. <a href="./references#CD000398-bbs2-0022" title="ISRCTN26986053 . Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial‐2. www.isrctn.com/ISRCTN26986053 (accessed prior to 6 April 2017). [ISRCTN26986053] ">RIGHT‐2 2015</a>)<i>.</i> </p> </section> <h3 class="title" id="CD000398-sec-0090">Implications for research</h3> <section id="CD000398-sec-0090"> <p>Large phase III randomised trials are required to assess the administration of NO donors in ultra‐acute and hyper‐acute strokes. </p> <p> <ul id="CD000398-list-0015"> <li> <p>The safety and efficacy of NO donors other than GTN.</p> </li> <li> <p>The safety and efficacy of GTN administered in the ultra‐acute phase/prehospital environment (e.g. <a href="./references#CD000398-bbs2-0022" title="ISRCTN26986053 . Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial‐2. www.isrctn.com/ISRCTN26986053 (accessed prior to 6 April 2017). [ISRCTN26986053] ">RIGHT‐2 2015</a>). </p> </li> <li> <p>The effect of GTN on long‐term functional outcome and death, i.e. beyond 90 days (e.g. <a href="./references#CD000398-bbs2-0022" title="ISRCTN26986053 . Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial‐2. www.isrctn.com/ISRCTN26986053 (accessed prior to 6 April 2017). [ISRCTN26986053] ">RIGHT‐2 2015</a>). </p> </li> <li> <p>Mechanisms by which GTN might work, e.g. potentially through reducing haematoma expansion in ICH, and improving collateral supply in ischaemic stroke (e.g. <a href="./references#CD000398-bbs2-0022" title="ISRCTN26986053 . Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial‐2. www.isrctn.com/ISRCTN26986053 (accessed prior to 6 April 2017). [ISRCTN26986053] ">RIGHT‐2 2015</a>). </p> </li> <li> <p>The health economics of GTN (although the low cost of treatment, i.e. &lt; £5 per patient, means that GTN will dominate if efficacy is seen for mRS). </p> </li> <li> <p>Whether there are particular subgroups who benefit, or do not benefit, from GTN.</p> </li> <li> <p>Whether GTN acts as adjunctive therapy to intravenous thrombolysis in ischaemic stroke.</p> </li> <li> <p>Whether GTN acts as adjunctive therapy to mechanical thrombectomy in ischaemic stroke.</p> </li> <li> <p>Whether GTN reduces the need for hospital‐based therapies such as mechanical thrombectomy, hemicraniectomy, need for rehabilitation therapy. </p> </li> <li> <p>Whether low and middle income countries can utilise GTN in the hyperacute period.</p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000398-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000398-sec-0022"></div> <div class="table" id="CD000398-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: people with acute stroke</b> </p> <p><b>Settings: pre‐hospital / hospital</b> </p> <p><b>Intervention: GTN</b> </p> <p><b>Comparison: no GTN</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Anticipated absolute effects (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with no GTN / placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with GTN compared with no GTN for acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or dependency (mRS&gt;2), end of trial (90 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>609 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>601 per 1,000</b> <br/> (573 to 631) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.97</b> </p> <p>(0.86 to 1.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4195 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death, end of trial (90 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>131 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>115 per 1,000</b> <br/> (90 to 184) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.78</b> <br/> (0.40 to 1.50) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life, end of trial (90 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life (EQ‐5D3L), end of trial ranged across control groups from 0.25 to 0.9. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life (EQ‐5D3L), end of trial in the intervention group was <b>0.01 lower (0.17 lower to 0.15 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4088 <br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health utility status derived from European Quality of life‐5 dimensions‐3 levels (EQ‐5D3L). Significant heterogeneity between trials (I<sup>2</sup> = 78%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Systolic BP, first treatment measurement (&lt;24 hours after randomisation)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean systolic BP, first treatment measurement ranged across control groups from 151.13 to 185.17 mmHg. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean systolic BP, first treatment measurement in the intervention group was <b>7.21 mmHg lower (8.58 lower to 5.85 lower)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diastolic BP, first treatment measurement (&lt;24 hours after randomisation)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean diastolic BP, first treatment measurement ranged across control groups from 82.34 to 91.0 mmHg. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean diastolic BP, first treatment measurement in the intervention group was <b>3.31 mmHg lower (4.18 lower to 2.45 lower)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Heart rate, first treatment measurement (&lt;24 hours after randomisation)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean heart rate, first treatment measurement ranged across control groups from 65.5 to 77.27 beats per minute. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean heart rate, first treatment measurement in the intervention group was <b>2.02 beats per minute higher (1.13 higher to 2.91 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant heterogeneity between trials (I<sup>2</sup> = 61%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Headache, on treatment (7‐12 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>84 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>180 per 1,000</b> </p> <p>(125 to 250)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 2.37</b> <br/> (1.55 to 3.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4186 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>BP: blood pressure; CI: confidence interval; GTN: glyceryl trinitrate; MD: mean difference; OR: odds ratio </p> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000398-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000398-sec-0023"></div> <section id="CD000398-sec-0024"> <h3 class="title" id="CD000398-sec-0024">Description of the condition</h3> <p>Stroke is the third most common cause of death and the most common cause of disability in the western world (<a href="./references#CD000398-bbs2-0053" title="MackayJ , MensahG . The Atlas of Heart Disease and Stroke. http://www.who.int/cardiovascular_diseases/resources/atlas/en/ (accessed prior to 6 April 2017). ">Mackay 2004</a>). Blood pressure (BP) is elevated in 75%, or more, of people with acute stroke (whether due to blockage (ischaemic stroke) or rupture (intracerebral haemorrhage (ICH)) of an artery), and half of those have an existing diagnosis of hypertension (<a href="./references#CD000398-bbs2-0028" title="BrittonM , CarlssonA , DeFaireU . Blood pressure course in patients with acute stroke and matched controls. Stroke1986;17(5):861‐4. ">Britton 1986</a>; <a href="./references#CD000398-bbs2-0063" title="OppenheimerS , HachinskiV . Complications of acute stroke. Lancet1992;339(8795):721‐4. ">Oppenheimer 1992</a>). In two‐thirds of people with stroke, BP spontaneously falls in the first week after stroke, whilst the remainder have high BP, which is associated with a poor outcome (<a href="./references#CD000398-bbs2-0081" title="WillmotM , Leonardi‐BeeJ , BathPMW . High blood pressure in acute stroke and subsequent outcome ‐ a systematic review. Hypertension2004;43(1):18‐24. ">Willmot 2004</a>). Systolic BP is related to outcome in a 'U‐shaped' relationship with both high and low systolic BP associated with increased death, and death or dependency (<a href="./references#CD000398-bbs2-0051" title="Leonardi‐BeeJ , BathPM , PhillipsSJ , SandercockPA , IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke2002;33(5):1315‐20. ">Leonardi‐Bee 2002</a>). Elevated systolic BP is also associated with early stroke recurrence (<a href="./references#CD000398-bbs2-0074" title="SpriggN , GrayLJ , BathPM , BoysenG , DeDeynPP , FriisP , TAIST Investigators. Relationship between outcome and baseline blood pressure and other haemodynamics in ischaemic stroke: data from the TAIST trial. Journal of Hypertension2006;24(7):1413‐7. ">Sprigg 2006</a>). </p> <p>Cerebral autoregulation maintains cerebral blood flow (CBF) despite changes in cerebral perfusion pressure (CPP: blood pressure supplying the brain). In acute stroke, autoregulation is lost so that cerebral perfusion becomes related to CPP, and therefore systemic BP (<a href="./references#CD000398-bbs2-0078" title="TikhonoffV , ZhangH , RichartT , StaessenJA . Blood pressure as a prognostic factor after acute stroke. Lancet Neurology2009;8(10):938‐48. ">Tikhonoff 2009</a>). Thus, large and precipitous reductions in BP reduce CBF, leading to further cerebral infarction (brain cell death from lack of blood flow; <a href="./references#CD000398-bbs2-0064" title="OwensWB . Blood pressure control in acute cerebrovascular disease. Journal of Clinical Hypertension2011;13(3):205‐11. ">Owens 2011</a>) or perihaematomal ischaemia (reduced blood flow to brain tissue surrounding the ICH; <a href="./references#CD000398-bbs2-0067" title="QureshiAI . Acute hypertensive response in patients with stroke ‐ pathophysiology and management. Circulation2008;118(2):176‐87. ">Qureshi 2008</a>). Similarly, high BP increases the risk of haematoma (bleed) growth in ICH, haemorrhagic transformation in ischaemic stroke, and cerebral oedema (brain swelling) in both stroke types (<a href="./references#CD000398-bbs2-0036" title="FaganSC , BowesMP , LydenPD , ZivinJA . Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol. Experimental Neurology1998;150(1):153‐8. ">Fagan 1998</a>; <a href="./references#CD000398-bbs2-0081" title="WillmotM , Leonardi‐BeeJ , BathPMW . High blood pressure in acute stroke and subsequent outcome ‐ a systematic review. Hypertension2004;43(1):18‐24. ">Willmot 2004</a>). </p> </section> <section id="CD000398-sec-0025"> <h3 class="title" id="CD000398-sec-0025">Description of the intervention</h3> <p>Nitric oxide (NO) (endothelium‐derived relaxing factor) is an endogenous (present within humans) inorganic soluble gas formed from the guanidino nitrogen of L‐arginine and molecular oxygen by the enzyme (catalyst) nitric oxide synthase (NOS) (<a href="./references#CD000398-bbs2-0065" title="PalmerRMJ , FerrigeAG , MoncadaS . Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature1987;327:524‐6. ">Palmer 1987</a>; <a href="./references#CD000398-bbs2-0066" title="PalmerRMJ , AshtonDS , MoncadaS . Vascular endothelial cells synthesise nitric oxide from L‐arginine. Nature1988;333:664‐6. ">Palmer 1988</a>). This enzyme is present within endothelial cells (endothelial NOS, eNOS, type III NOS) and some neurones (brain cells; neuronal NOS, nNOS, type I NOS) in a calcium‐dependent constitutive form (<a href="./references#CD000398-bbs2-0049" title="KnowlesRG , PalaciosM , PalmerRM , MoncadaS . Formation of nitric oxide from L‐arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Sciences of the United States of America1989;86:5159‐62. ">Knowles 1989</a>), and in macrophages (white blood cells), astrocytes, microglia (brain cells), and vascular smooth muscle cells (inducible NOS, iNOS, type II NOS) in a calcium‐independent inducible form (<a href="./references#CD000398-bbs2-0038" title="FlemingI , GrayGA , SchottC , StocletJC . Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. European Journal of Pharmacology1991;200:375‐6. ">Fleming 1991</a>; <a href="./references#CD000398-bbs2-0029" title="ChoHJ , XieQW , CalaycayJ , MumfordRA , SwiderekKM , LeeTD , et al. Calmodulin is a subunit of nitric oxide synthase from macrophages. Journal of Experimental Medicine1992;176:599‐604. ">Cho 1992</a>). NO is one of the most versatile molecules in animal and human biology with diverse roles in both physiology and pathophysiology: it is a vasodilator (dilates blood vessels) with anti‐smooth muscle cell activity (<a href="./references#CD000398-bbs2-0059" title="MuradF , WaldmanS , MolinaC , BennettB , LeitmanD . Regulation and role of guanylate cyclase‐cyclic GMP in vascular relaxation. Progress in Clinical and Biological Research1987;249:65‐76. ">Murad 1987</a>); protects endothelium; inhibits platelet (circulating cell fragments involved in clotting) adhesion and aggregation (<a href="./references#CD000398-bbs2-0068" title="RadomskiMW , PalmerRMJ , MoncadaS . Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet1987;ii:1057‐8. ">Radomski 1987a</a>; <a href="./references#CD000398-bbs2-0069" title="RadomskiMW , PalmerRMJ , MoncadaS . The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. British Journal of Pharmacology1987;92:639‐46. ">Radomski 1987b</a>) and leucocyte (white blood cells) adhesion and chemotaxis (movement of cells to an attractant) (<a href="./references#CD000398-bbs2-0027" title="BathPMW , HassallDG , GladwinAM , PlamerRMJ , MartinJF . Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterisclerosis &amp; Thrombosis1991;11:254‐60. ">Bath 1991</a>), and has other anti‐inflammatory properties. Further, it is a neurotransmitter and neuromodulator (chemical messenger) (<a href="./references#CD000398-bbs2-0039" title="GarthwaiteJ , CharlesSL , Chess‐WilliamsR . Endothelium derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature1988;336:385‐8. ">Garthwaite 1988</a>; <a href="./references#CD000398-bbs2-0055" title="ManzoniO , PrezeauL , MarinP , DeshagerS , BockaertJ , FagniL . Nitric oxide induced blockade of NMDA receptors. Neuron1992;8:653‐62. ">Manzoni 1992</a>; <a href="./references#CD000398-bbs2-0032" title="DawsonTM , SnyderSH . Gases as biological messengers: nitric oxide and carbon monoxide in the brain. Journal of Neuroscience1994;14:5147‐59. ">Dawson 1994</a>), and is involved in cerebral blood flow auto‐ and chemo‐regulation (control of brain blood flow) (<a href="./references#CD000398-bbs2-0077" title="TanakaK . Is nitric oxide really important for regulation of the cerebral circulation? Yes or no?. Keio Journal of Medicine1996;45:14‐27. ">Tanaka 1996</a>; <a href="./references#CD000398-bbs2-0080" title="WhiteRP , VallanceP , MarkusHS . Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clinical Science2000;99:555‐60. ">White 2000</a>; <a href="./references#CD000398-bbs2-0050" title="LaviS , EgbaryaR , LaviR , JacobG . Role of nitric oxide in the regulation of cerebral blood flow in humans: chemoregulation versus mechanoregulation. Circulation2003;107:1901‐5. ">Lavi 2003</a>). </p> <p>In experimental pre‐clinical studies of ischaemic stroke, significant changes relating to NO occur in a time‐dependent fashion. In models of focal ischaemic stroke, there is increased NO production for up to 30 minutes following middle cerebral artery occlusion or blockage (<a href="./references#CD000398-bbs2-0048" title="KaderA , FrazziniVI , SolomonRA , TrifilettiRR . Nitric oxide production during focal cerebral ischemia in rats. Stroke1993;24:1709‐16. ">Kader 1993</a>; <a href="./references#CD000398-bbs2-0054" title="MalinskiT , BaileyF , ZhangZG , ChoppM . Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. Journal of Cerebral Blood Flow &amp; Metabolism1993;13:355‐8. ">Malinski 1993</a>), likely due to increased calcium availability and nNOS activation (<a href="./references#CD000398-bbs2-0044" title="HuangZ , HuangPL , PanahianN , DalkaraT , FishmanMC , MoskowitzMA . Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science1994;265:1883‐5. ">Huang 1994</a>). eNOS and nNOS activity increases in line with NO within the first minutes following middle cerebral artery occlusion and significantly reduces thereafter (<a href="./references#CD000398-bbs2-0048" title="KaderA , FrazziniVI , SolomonRA , TrifilettiRR . Nitric oxide production during focal cerebral ischemia in rats. Stroke1993;24:1709‐16. ">Kader 1993</a>), whilst iNOS is upregulated (increased activity) from 12 hours after the event, this lasting for up to seven days (<a href="./references#CD000398-bbs2-0061" title="NiwaM , InaoS , TakayasuM , KawaiT , KahitaY , NihashiT , et al. Time course of expression of three nitric oxide synthase isoforms after transient middle cerebral artery occlusion in rats. Neurologia Medico‐Chirurgica2001;41:63‐72. ">Niwa 2001</a>). Within brain tissue, NO is undetectable for up to seven days following ictus (stroke onset) (<a href="./references#CD000398-bbs2-0054" title="MalinskiT , BaileyF , ZhangZG , ChoppM . Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. Journal of Cerebral Blood Flow &amp; Metabolism1993;13:355‐8. ">Malinski 1993</a>). </p> <p>Intravenous (injected into a vein) L‐arginine given after middle cerebral artery occlusion improved cerebral blood flow within the ischaemic penumbra (area of brain tissue surrounding the infarct that is at risk of infarction) and reduced infarct size and volume (<a href="./references#CD000398-bbs2-0056" title="MorikawaE , HuangZ , MoskowitzMA . L‐arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. American Journal of Physiology1992;263:H1632‐5. ">Morikawa 1992a</a>; <a href="./references#CD000398-bbs2-0058" title="MorikawaE , MoskowitzMA , HuangZ , YoshidaT , IrikuraK , DalkaraT . L‐arginine infusion promotes nitric oxide‐dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke1994;25:429‐35. ">Morikawa 1994</a>). However, this observation was not seen in eNOS‐deficient mice, who also have lower post‐ischaemic cerebral blood flow, larger infarcts, smaller penumbral areas (<a href="./references#CD000398-bbs2-0045" title="HuangZ , HuangPL , MaJ , MengW , AyataC , FishmanMC , et al. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro‐L‐arginine. Journal of Cerebral Blood Flow &amp; Metabolism1996;16:981‐7. ">Huang 1996</a>; <a href="./references#CD000398-bbs2-0052" title="LoEH , HaraH , RogowskaJ , TrochaM , PierceAR , HuangPL , et al. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke1996;27:1381‐5. ">Lo 1996</a>), and absent angiogenesis (development of new blood vessels), potentially leading to increased post‐ischaemic damage (<a href="./references#CD000398-bbs2-0031" title="CuiX , ChoppM , ZacharekA , ZhangC , RobertsC , ChenJ . Role of endothelial nitric oxide synthase in arteriogenesis after stroke in mice. Neuroscience2009;159:744‐50. ">Cui 2009</a>). The advantageous effects of eNOS activity are supported by evidence that eNOS phosphorylation‐deficient mice (mice with inactive eNOS) (<a href="./references#CD000398-bbs2-0024" title="AtochinDN , WangA , LiuVW , CritchlowJD , DantasAP , Looft‐WilsonR , et al. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. Journal of Clinical Investigation2007;117:1961‐7. ">Atochin 2007</a>) and mice deficient in the alpha‐1 subunit of soluble guanylate cyclase have increased infarct size (<a href="./references#CD000398-bbs2-0025" title="AtochinDN , YuzawaI , LiQ , RauwerdinkKM , MalhotraR , ChangJ , et al. Soluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury. Stroke2010;41:1815‐9. ">Atochin 2010</a>). Whilst eNOS and eNOS‐derived NO are neuroprotective (protecting brain cells against further damage) following cerebral infarction, nNOS‐derived NO (<a href="./references#CD000398-bbs2-0044" title="HuangZ , HuangPL , PanahianN , DalkaraT , FishmanMC , MoskowitzMA . Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science1994;265:1883‐5. ">Huang 1994</a>; <a href="./references#CD000398-bbs2-0042" title="HaraH , HuangPL , PanahianN , FishmanMC , MoskowitzMA . Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. Journal of Cerebral Blood Flow &amp; Metabolism1996;16:605‐11. ">Hara 1996</a>; <a href="./references#CD000398-bbs2-0083" title="ZaharchukG , HaraH , HuangPL , FishmanMC , MoskowitzMA , JenkinsBG , et al. Neuronal nitric oxide synthase mutant mice show smaller infarcts and attenuated diffusion coefficient changes in the peri‐infarct zone during focal cerebral ischemia. Magnetic Resonance in Medicine1997;37:170‐5. ">Zaharchuk 1997</a>) and iNOS‐derived NO (<a href="./references#CD000398-bbs2-0046" title="IadecolaC , ZhangF , XuX . Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. American Journal of Physiology1995;268:R286‐92. ">Iadecola 1995</a>; <a href="./references#CD000398-bbs2-0084" title="ZhangF , CaseyRM , RossME , IadecolaC . Aminoguanidine ameliorates and L‐arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke1996;27:317‐23. ">Zhang 1996</a>; <a href="./references#CD000398-bbs2-0047" title="IadecolaC , ZhangF , CaseyR , NagayamaM , RossME . Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. Journal of Neuroscience1997;17:9157‐64. ">Iadecola 1997</a>; <a href="./references#CD000398-bbs2-0085" title="ZhaoX , RossME , IadecolaC . L‐arginine increases ischemic injury in wild‐type mice but not in iNOS‐deficient mice. Brain Research2003;966:308‐11. ">Zhao 2003</a>) are detrimental to tissue survival resulting in poorer neurological outcome. Despite being neurotoxic in the acute phase following stroke, iNOS and nNOS seem to be important in neurogenesis (formation of new brain cells) post‐stroke, with iNOS promoting (<a href="./references#CD000398-bbs2-0073" title="SeharaY , HayashiT , DeguchiK , NagotaniS , ZhangH , ShojiM , et al. Distribution of inducible nitric oxide synthase and cell proliferation in rat brain after transient middle cerebral artery occlusion. Brain Research2006;1093:190‐7. ">Sehara 2006</a>; <a href="./references#CD000398-bbs2-0030" title="CorsaniL , BizzocoE , PedataF , GianfriddoM , Faussone‐PellegriniMS , VannucchiMG . Inducible nitric oxide synthase appears and is co‐expressed with the neuronal isoform in interneurons of the rat hippocampus after transient ischemia induced by middle cerebral artery occlusion. Experimental Neurology2008;211:433‐40. ">Corsani 2008</a>) and nNOS attenuating this process (<a href="./references#CD000398-bbs2-0076" title="SunY , JinK , ChildsJT , XieL , MaoXO , GreenbergDA . Neuronal nitric oxide synthase and ischemia‐induced neurogenesis. Journal of Cerebral Blood Flow &amp; Metabolism2005;25:485‐92. ">Sun 2005</a>). </p> <p>With the weight of evidence for NO‐mediated neuroprotection post‐stroke, several therapeutic strategies have been proposed: replacement or supplementation of NO deficiency through administration of NO, NO donors or precursors; enhancement of eNOS activity to modulate or increase endogenous NO production (<a href="./references#CD000398-bbs2-0035" title="EndresM , LaufsU , LiaoJK , MoskowitzMA . Targeting eNOS for stroke protection. Trends in Neurosciences2004;27:283‐9. ">Endres 2004</a>); and direct or indirect inhibition of NOS. </p> </section> <section id="CD000398-sec-0026"> <h3 class="title" id="CD000398-sec-0026">How the intervention might work</h3> <p>Vascular NO levels are low in acute stroke and so replacement might be beneficial (<a href="./references#CD000398-bbs2-0037" title="FerlitoS , GallinaM , PitariGM , BianchiA . Nitric oxide plasma levels in patients with chronic and acute cerebrovascular disorders. Panminerva Medicine1998;40:51‐4. ">Ferlito 1998</a>; <a href="./references#CD000398-bbs2-0070" title="RashidPA , WhitehurstA , LawsonN , BathPMW . Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome. Journal of Stroke and Cerebrovascular Diseases2003;12:82‐7. ">Rashid 2003</a>). NO, however delivered, may have multiple effects that could improve outcome after stroke. </p> <p> <ul id="CD000398-list-0001"> <li> <p>BP lowering: NO donors (intravenous sodium nitroprusside (SNP) and transdermal glyceryl trinitrate (GTN)) lower BP, pulse pressure, and peak systolic BP; improve arterial compliance; and maintain CBF in acute stroke (<a href="./references#CD000398-bbs2-0006" title="ButterworthRJ , CluckieA , JacksonSHD , Buxton‐ThomasM , BathPMW . Sodium nitroprusside, a spontaneous nitric oxide donor in acute ischaemic stroke. Cerebrovascular Diseases1998;8:158‐65. ">Butterworth 1998</a>; <a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). Whilst SNP inhibits platelet function, thereby negating its use in ICH (<a href="./references#CD000398-bbs2-0006" title="ButterworthRJ , CluckieA , JacksonSHD , Buxton‐ThomasM , BathPMW . Sodium nitroprusside, a spontaneous nitric oxide donor in acute ischaemic stroke. Cerebrovascular Diseases1998;8:158‐65. ">Butterworth 1998</a>), GTN has no effect on platelets and can therefore be used in people with stroke, regardless of stroke type (<a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>). </p> </li> <li> <p>Reperfusion (improving blood supply): NO dilates cerebral arteries and could then increase perilesional perfusion (blood flow around the stroke lesion via the 'front door') without inducing cerebral steal (<a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). Pial artery (brain surface artery) blood flow and, therefore, collateral flow may provide 'back‐door' reperfusion to the ischaemic penumbra in ischaemic stroke (<a href="./references#CD000398-bbs2-0057" title="MorikawaE , RosenblattS , MoskowitzMA . L‐arginine dilates rat pial arterioles by nitric oxide‐dependent mechanisms and increases blood flow during focal cerebral ischaemia. British Journal of Pharmacology1992;107(4):905‐7. ">Morikawa 1992b</a>) and the perihaematomal region in ICH. </p> </li> <li> <p>Cytoprotection (cell protection): NO exhibits neuroprotective effects, as found in experimental studies (see above). Whether these effects involve cellular protection per se or just reflect reperfusion remains unclear. </p> </li> </ul> </p> <p>NO donors could also have adjunctive effects, enhancing the effects of existing reperfusion therapies by: </p> <p> <ul id="CD000398-list-0002"> <li> <p>Lowering BP: NO donors may prepare people with hyper‐acute (within a few hours) ischaemic stroke for thrombolysis (clot‐dissolving therapy; non‐significant tendencies to more and earlier intravenous thrombolysis were seen in the pilot RIGHT trial (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>); </p> </li> <li> <p>Dilating cerebral arteries around occluding clot, NO donors may enhance access to the clot by both endogenous and exogenous fibrinolysis (clot‐dissolving compounds found within the body and administered as treatment). </p> </li> </ul> </p> </section> <section id="CD000398-sec-0027"> <h3 class="title" id="CD000398-sec-0027">Why it is important to do this review</h3> <p>Evidence‐based treatments for acute stroke are limited. In hyper‐acute ischaemic stroke, there are interventions with high efficacy but limited utility (intravenous thrombolysis (<a href="./references#CD000398-bbs2-0034" title="EmbersonJ , LeesKR , LydenP , BlackwellL , AlbersG , BluhmkiE , Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta‐analysis of individual patient data from randomised trials. Lancet2014;384(9958):1929‐35. ">Emberson 2014</a>); thrombectomy (removal of clot causing large vessel occlusion) (<a href="./references#CD000398-bbs2-0040" title="GoyalM , MenonBK , VanZwamWH , DippelDWJ , MitchellPJ , DemchukAM , the HERMES Collaborators. Endovascular thrombectomy after large‐vessel ischaemic stroke: a meta‐analysis of individual patient data from five randomised trials. Lancet2016;387(10029):1723‐31. ">Goyal 2016</a>); and decompressive hemicraniectomy (surgery to remove one side of the skull to relieve intracranial pressure) (<a href="./references#CD000398-bbs2-0079" title="VahediK , HofmeijerJ , JuettlerE , VicautE , GeorgeB , AlgraA , DECIMAL , DESTINY , and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurology2007;6(3):215‐22. ">Vahedi 2007</a>)), and those with low efficacy but high utility (aspirin (<a href="./references#CD000398-bbs2-0072" title="SandercockPAG , CounsellC , TsengMC , CecconiE . Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD000029.pub3] ">Sandercock 2014</a>)). In comparison, there are no definitive treatments for ICH other than early BP lowering (<a href="./references#CD000398-bbs2-0023" title="AndersonCS , HeeleyE , HuangY , WangJ , StapfC , DelcourtC , INTERACT2 Investigators. Rapid blood‐pressure lowering in patients with acute intracerebral hemorrhage. New England Journal of Medicine2013;368(25):2355‐65. ">Anderson 2013</a>). All patients with stroke should have access to stroke unit care (<a href="./references#CD000398-bbs2-0075" title="Stroke Unit Triallists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews2013, Issue 9. [DOI: 10.1002/14651858.CD000197.pub3] ">Stroke Unit Trialists' Collaboration 2013</a>). </p> <p>NO donors are inexpensive (e.g. GTN costs approximately £1 per patch) and, if efficacious, could be used in low, middle, and high income economies. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000398-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000398-sec-0028"></div> <p>To assess the safety and efficacy of NO donors, L‐arginine, or NOS‐I in people with acute stroke. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000398-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000398-sec-0029"></div> <section id="CD000398-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000398-sec-0031"> <h4 class="title">Types of studies</h4> <p>Published and unpublished randomised controlled trials (RCTs) of NO donors, L‐arginine, or NOS‐I in people with stroke randomised within one week of ictus with either acute ischaemic stroke or ICH. We excluded studies of people with subarachnoid haemorrhage, uncontrolled studies, and confounded controlled studies (i.e. where two or more active interventions were compared). </p> </section> <section id="CD000398-sec-0032"> <h4 class="title">Types of participants</h4> <p>Men and women of any age with recent ischaemic stroke or intracerebral haemorrhage (ICH) eligible for randomisation to active treatment or control. </p> </section> <section id="CD000398-sec-0033"> <h4 class="title">Types of interventions</h4> <p>NO donors, L‐arginine, and/or NOS‐I given by any route of administration versus placebo or open control. </p> </section> <section id="CD000398-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>We assessed haemodynamic measures after first treatment, and clinical measures at end of treatment and end of follow‐up. </p> <section id="CD000398-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>End‐of‐trial death or dependency, defined as modified Rankin Scale (mRS) &gt; 2. The mRS is a 7‐level ordinal hierarchical scale ascribing a score to grades of disability from 0: no symptoms; 1: symptoms but independent; 2: mostly independent but needs some help; 3: moderate dependency but can walk; 4: dependency needing help for walking and bodily needs; 5: severe dependency and bedridden; and 6: death. </p> </section> <section id="CD000398-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD000398-list-0003"> <li> <p>First blood pressure and heart rate measurements after randomisation</p> </li> <li> <p>Early case fatality (end of treatment)</p> </li> <li> <p>Late case fatality (end of trial)</p> </li> <li> <p>Early neurological deterioration by end of treatment defined as a decrease in the Scandinavian Stroke Scale (SSS) by &gt; 5 points or a decrease in the consciousness part of the SSS by &gt; 2 points </p> </li> <li> <p>Headache on treatment</p> </li> <li> <p>Treatment stopped early</p> </li> <li> <p>National Institutes of Health Stroke Scale (NIHSS) at end of treatment derived from SSS (<a href="./references#CD000398-bbs2-0041" title="GrayLJ , AliM , LydenPD , BathPM , Virtual International Stroke Trials Archive Collaboration. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. Journal of Stroke and Cerebrovascular Diseases2009;18:466‐8. ">Gray 2009</a>) </p> </li> <li> <p>Late dependency or disability defined as end‐of‐trial Barthel Index (BI)</p> </li> <li> <p>Mood at end‐of‐trial using the short‐form Zung Depression Scale (<a href="./references#CD000398-bbs2-0086" title="ZungWW . A self‐rating depression scale. Archives of General Psychiatry1965;12:63‐70. ">Zung 1965</a>) </p> </li> <li> <p>Quality of life at end‐of‐trial using health utility status derived from European Quality of life‐5 dimensions‐3 levels (EQ‐5D3L) and EQ‐visual analogue scale (EQ‐VAS) </p> </li> <li> <p>Cognition at end‐of‐trial using telephone Mini‐Mental State Examination (t‐MMSE, subscore derived from MMSE), telephone interview cognition scale (TICS) and verbal fluency (animal naming) </p> </li> <li> <p>Physiotherapy during hospital stay</p> </li> <li> <p>Occupational therapy during hospital stay</p> </li> <li> <p>Speech and language therapy during hospital stay</p> </li> <li> <p>Feeding route (non‐oral feeding at day seven)</p> </li> <li> <p>Length of hospital stay (days)</p> </li> </ul> </p> </section> </section> </section> <section id="CD000398-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <p>See the 'Specialized register' section in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/STROKE/frame.html" target="_blank">Cochrane Stroke Group</a> module. We did not apply any language restrictions and sought translations of articles where required. </p> <section id="CD000398-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Stroke Group Trials Register (last searched 6 February 2017), MEDLINE (Ovid) (1966 to June 2016, <a href="./appendices#CD000398-sec-0094">Appendix 1</a>), Embase (Ovid) (1980 to June 2016, <a href="./appendices#CD000398-sec-0095">Appendix 2</a>), Science Citation Index (ISI, Web of Science, 1900 to June 2016, <a href="./appendices#CD000398-sec-0096">Appendix 3</a>), Stroke Trials Registry (<a href="http://www.strokecenter.org/trials" target="_blank">www.strokecenter.org/trials</a>, searched June 2016), International Standard Randomised Controlled Trial Number (ISRCTN) registry (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>, searched June 2016), Clinical Trials registry (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, searched June 2016), and the International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.apps.who.int/trialsearch/" target="_blank">www.apps.who.int/trialsearch/</a>, searched June 2016). </p> </section> <section id="CD000398-sec-0039"> <h4 class="title">Searching other resources</h4> <p>For the 2002 version of this review we contacted pharmaceutical companies who made nitric oxide donors (Schwarz Pharma, Schering‐Plough) or nitric oxide synthase inhibitors (GlaxoWellcome) and researchers in the field to help identify relevant trials (<a href="./references#CD000398-bbs2-0087" title="BathPMW , WillmotMM , Leonardi‐BeeJ , Bath‐HextallFJ . Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD000398] ">Bath 2002</a>). For this update, we also searched references lists of included studies and systematic reviews. </p> </section> </section> <section id="CD000398-sec-0040"> <h3 class="title" id="CD000398-sec-0040">Data collection and analysis</h3> <p>We extracted data using a standard proforma, which one review author (JA) entered into Review Manager 5 (<a href="./references#CD000398-bbs2-0071" title="Nordic Cochrane Centre, the Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, the Cochrane Collaboration, 2014. ">RevMan 2014</a>) and another review author (KK) checked. </p> <section id="CD000398-sec-0041"> <h4 class="title">Selection of studies</h4> <p>One author (JA) screened the outputs from the electronic searches, and excluded irrelevant studies. We obtained full paper copies of the remaining studies and both review authors (JA and PB) selected studies based on the aforementioned inclusion criteria. We resolved any disagreements through discussion. </p> </section> <section id="CD000398-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>We extracted data from published and unpublished material. We recorded information on the following parameters: randomisation method; allocation concealment; blinding of treatment; analysis method; stroke type; treatment type, dose, route of administration and timing; blood pressure and heart rate during treatment; case fatality; functional status; quality of life; mood; cognition; length of hospital stay; rates of physiotherapy, occupational therapy and speech and language therapy; and feeding status. Individual patient data were available for all included trials and this allowed subgroup analyses and calculation of means and standard deviations to facilitate parametric analyses of ordinal outcomes such as mRS. The search criteria did not require that individual patient data were present in the included studies. </p> </section> <section id="CD000398-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed risk of bias in the included studies using Cochrane's 'Risk of bias' tool, which is based on the following domains: </p> <p> <ul id="CD000398-list-0004"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective reporting.</p> </li> <li> <p>Other sources of bias.</p> </li> </ul> </p> <p>Each domain includes one or more specific entries in a 'Risk of bias' table. Within each entry, the first part of the tool describes what was reported to have happened in the study in sufficient detail to support a judgement on the risk of bias. The second part assigns a judgement relating to the risk of bias: 'Low risk' of bias, 'High risk' of bias, or 'Unclear risk' of bias, according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000398-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD000398-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated the weighted estimate of the typical treatment effect across trials using RevMan 5.3 (<a href="./references#CD000398-bbs2-0071" title="Nordic Cochrane Centre, the Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, the Cochrane Collaboration, 2014. ">RevMan 2014</a>). We calculated odds ratios (OR) using the Mantel‐Haenszel random‐effects model for binary data, and mean difference (MD) using the inverse variance method for continuous data, all with 95% confidence intervals (CIs). </p> </section> <section id="CD000398-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>Where stroke severity was measured by the Scaninavian Stroke Scale (SSS), the National Institutes of Health Stroke Scale (NIHSS) score was calculated using a published conversion algorithm (<a href="./references#CD000398-bbs2-0041" title="GrayLJ , AliM , LydenPD , BathPM , Virtual International Stroke Trials Archive Collaboration. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. Journal of Stroke and Cerebrovascular Diseases2009;18:466‐8. ">Gray 2009</a>). Since many scales include a value for people who have died (e.g. modified Rankin Scale = 6, Health Utility Status = 0, Barthel Index = ‐5), extreme worst values were assigned for death for other outcomes including mood (short‐form Zung Depression Scale (<a href="./references#CD000398-bbs2-0086" title="ZungWW . A self‐rating depression scale. Archives of General Psychiatry1965;12:63‐70. ">Zung 1965</a>) = 102.5; EQ‐VAS = ‐1; t‐MMSE = ‐1; TICS = ‐1; and animal naming = ‐1). Where secondary outcomes were not assessed, trials were excluded from analysis of that particular outcome. </p> </section> <section id="CD000398-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We made extensive attempts to find missing data, including utilising unpublished data from study authors. </p> </section> <section id="CD000398-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We calculated heterogeneity between RCT results using the I<sup>2</sup> statistic based upon the DerSimonian‐Laird formula (<a href="./references#CD000398-bbs2-0033" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7:177‐88. ">DerSimonian 1986</a>). </p> </section> <section id="CD000398-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>We demonstrated reporting bias using funnel plots.</p> </section> <section id="CD000398-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We performed statistical analysis using RevMan 5.3 (<a href="./references#CD000398-bbs2-0071" title="Nordic Cochrane Centre, the Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, the Cochrane Collaboration, 2014. ">RevMan 2014</a>). We reported outcomes for dichotomous data as OR with 95% CIs, and continuous data as MD with 95% CIs. We used random‐effects models to analyse individual results, a conservative approach appropriate for the heterogenous designs and populations of the trials involved. We used fixed‐effect models to analyse haemodynamic variables, given the size and precision of <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a> in relation to the other included studies. </p> <section id="CD000398-sec-0050"> <h5 class="title">Summary of findings table</h5> <p>We presented the primary outcome and important secondary outcomes (including quality of life) of the review in <a href="./full#CD000398-tbl-0001">summary of findings Table for the main comparison</a>. We used the GRADE approach to assess the quality of the supporting evidence for each analysis. We downgraded quality depending upon: limitations in study design and implementation suggesting a high potential of bias; unexplained heterogeneity or inconsistency of results; imprecision of results (wide CIs); indirectness of evidence; or publication bias. </p> </section> </section> <section id="CD000398-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We reviewed the primary and secondary outcomes in the following prespecified subgroups.</p> <p> <ul id="CD000398-list-0005"> <li> <p>Intervention type</p> </li> <li> <p>Type of stroke: ischaemic stroke or ICH</p> </li> <li> <p>Time from stroke onset to randomisation: ≤ 6 hours; 6.1 to 12 hours; 12.1 to 24 hours; 24.1 to 36 hours; and &gt; 36 hours </p> </li> <li> <p>Baseline systolic blood pressure (systolic BP): ≤ 160 mmHg; 160.1 to 180 mmHg; 180.1 to 200 mmHg; &gt; 200 mmHg </p> </li> </ul> </p> <p>We considered heterogeneity to be significant if I<sup>2</sup> was greater than 50%; if present, we sought the potential reasons, e.g. different trial designs, trial populations, time to treatment. If individual subgroups had zero participants in either the intervention or no intervention arms, then we excluded the trial concerned from that particular individual subgroup analysis. As a result, the denominators for subgroups analyses vary. </p> </section> <section id="CD000398-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>Since ordinal or continuous analyses are more sensitive to treatment effects than dichotomous measures (<a href="./references#CD000398-bbs2-0062" title="Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical re‐analysis of functional outcomes in stroke trials. Stroke2007;38:1911‐5. ">OAST 2007</a>), we assessed the comparison of the primary outcome, mRS, as MD in addition to OR. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000398-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000398-sec-0053"></div> <section id="CD000398-sec-0054"> <h3 class="title">Description of studies</h3> <p>We included five randomised trials of participants with ultra‐acute, hyper‐acute, acute and sub‐acute stroke. </p> <section id="CD000398-sec-0055"> <h4 class="title">Results of the search</h4> <p><a href="#CD000398-fig-0001">Figure 1</a> shows the PRISMA study flow diagram. Of the 4772 records identified and screened, we excluded 4750. After full‐text review of the remaining 22 studies, we excluded 16 studies including four ongoing studies that did not meet eligibility criteria. One study met inclusion criteria but is currently ongoing. Therefore, we included five trials, which are completed and summarised in <a href="./references#CD000398-sec-0106" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD000398-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Results of Database Search" data-id="CD000398-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Results of Database Search</p> </div> </div> </div> </section> <section id="CD000398-sec-0056"> <h4 class="title">Included studies</h4> <p>We identified five trials that fulfilled the inclusion criteria (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). All five trials involved administration of transdermal glyceryl trinitrate (GTN) 5 to 10 mg daily via a patch. Individual patient data were provided for all five studies, totaling 4197 participants. All studies recruited participants with mixed stroke (ischaemic stroke and ICH). One of the trials was multicentre and international (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>), whilst the remainder were UK‐based, single‐centre studies. </p> <p>Trial recruitment occurred at different time intervals following stroke:</p> <p> <ul id="CD000398-list-0006"> <li> <p>within four hours of onset (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>); </p> </li> <li> <p>within 48 hours of onset (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>); </p> </li> <li> <p>within 72 hours of onset (<a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>); </p> </li> <li> <p>within 168 hours of onset (<a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). </p> </li> </ul> </p> <p>The duration of the intervention period varied:</p> <p> <ul id="CD000398-list-0007"> <li> <p>seven days (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>10 days (<a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>); </p> </li> <li> <p>12 days (<a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>). </p> </li> </ul> </p> <p>Four studies used transdermal GTN patch 5 mg once daily (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>), whilst <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a> adopted a different strategy with three treatment groups: transdermal GTN patch 5 mg once daily for 10 days; 5 mg for four days then 10 mg for six days; and 10 mg for 10 days. For this review, as with a previous version (2002), we combined the three treatment arms into one group. All studies detailed the equipment used and patient posture when blood pressure recordings were performed. </p> <p>Multiple outcomes were reported:</p> <p> <ul id="CD000398-list-0008"> <li> <p>mRS end‐of‐trial in all studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>BI end‐of‐trial in all studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>case fatality at end‐of‐treatment and end‐of‐trial in all studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>early neurological deterioration by end‐of‐treatment in four studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>mood (Zung Depression Scale) end‐of‐trial in three studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>quality of life (EQ‐5D and EQ‐VAS) end‐of‐trial in four studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>cognition at end‐of‐trial in three studies: MMSE (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>), t‐MMSE (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>), TICS (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>), animal naming (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>); </p> </li> <li> <p>physiotherapy, occupational therapy and speech and language therapy rates in three studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>feeding route (non‐oral feeding at day seven) in three studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>); </p> </li> <li> <p>length of stay in four studies (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). </p> </li> </ul> </p> </section> <section id="CD000398-sec-0057"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 studies that either lacked randomisation, were uncontrolled, were confounded, or were not relevant to this review (<a href="./references#CD000398-sec-0107" title="">Characteristics of excluded studies</a>); four of these are ongoing studies. One other study met the inclusion criteria and is currently ongoing (<a href="./references#CD000398-sec-0108" title="">Characteristics of ongoing studies</a>). </p> </section> </section> <section id="CD000398-sec-0058"> <h3 class="title">Risk of bias in included studies</h3> <p>For full details see the corresponding 'Risk of bias' tables in <a href="./references#CD000398-sec-0106" title="">Characteristics of included studies</a>, and <a href="#CD000398-fig-0002">Figure 2</a> and <a href="#CD000398-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD000398-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000398-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD000398-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000398-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD000398-sec-0059"> <h4 class="title">Allocation</h4> <p>Randomisation can be summarised as follows (<a href="./references#CD000398-sec-0106" title="">Characteristics of included studies</a>). </p> <p> <ul id="CD000398-list-0009"> <li> <p>Simple randomisation 1:1 (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>) was deemed at low risk of selection bias and ensured allocation concealment. </p> </li> <li> <p>Computer minimisation 1:1 (<a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>) were deemed at low risk of selection bias and ensured allocation concealment. </p> </li> <li> <p>Computer minimisation 2:1 (<a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>) was deemed at low risk of selection bias and ensured allocation concealment. </p> </li> </ul> </p> </section> <section id="CD000398-sec-0060"> <h4 class="title">Blinding</h4> <p>Participants and investigators were blinded to treatment as follows.</p> <p> <ul id="CD000398-list-0010"> <li> <p>Double‐blind (participant and investigator): one trial (<a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>). </p> </li> <li> <p>Single‐blind (participant): three trials (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). </p> </li> <li> <p>Open‐label: one trial (<a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>). </p> </li> </ul> </p> <p>Blinding of participants and personnel (performance bias) were deemed unclear risk for the three single‐blind trials (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>) and the open‐label trial (<a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>). Blinding of outcome assessment (detection bias) was deemed low risk for all included trials as outcomes were assessed centrally blinded to treatment group. </p> </section> <section id="CD000398-sec-0061"> <h4 class="title">Incomplete outcome data</h4> <p>All five included trials were analysed by intention‐to‐treat with no differences in follow‐up rates between treatment groups. </p> </section> <section id="CD000398-sec-0062"> <h4 class="title">Selective reporting</h4> <p>The likelihood of reporting bias was demonstrated using funnel plots (<a href="#CD000398-fig-0004">Figure 4</a>; <a href="#CD000398-fig-0005">Figure 5</a>) and was not evident in any of the included trials. <a href="#CD000398-fig-0004">Figure 4</a> assessed the primary outcome (mRS end‐of‐trial) across the included studies, whilst <a href="#CD000398-fig-0005">Figure 5</a> assessed the first BP measurement after treatment; this was included because it was the primary outcome in the four phase II trials. </p> <div class="figure" id="CD000398-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome: 1.1 Death or dependency (mRS&gt;2), end of trial." data-id="CD000398-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome: 1.1 Death or dependency (mRS&gt;2), end of trial. </p> </div> </div> </div> <div class="figure" id="CD000398-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, outcome: 1.81 Systolic BP, first treatment measurement." data-id="CD000398-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, outcome: 1.81 Systolic BP, first treatment measurement. </p> </div> </div> </div> </section> <section id="CD000398-sec-0063"> <h4 class="title">Other potential sources of bias</h4> <p>We did not identify any other potential sources of bias that might have impacted upon the validity of the included studies. </p> </section> </section> <section id="CD000398-sec-0064"> <h3 class="title" id="CD000398-sec-0064">Effects of interventions</h3> <p>See: <a href="./full#CD000398-tbl-0001"><b>Summary of findings for the main comparison</b> Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</a> </p> <section id="CD000398-sec-0065"> <h4 class="title">Death or dependency, end of trial</h4> <p>Death or dependency was assessed as mRS &gt; 2 at day 90 in all five included trials totaling 4195 participants (<a href="./full#CD000398-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./references#CD000398-fig-0006" title="">Analysis 1.1</a>). There was no significant difference between GTN and control (OR 0.97, 95% CI 0.86 to 1.10), and no evidence of heterogeneity (I<sup>2</sup> = 0%). When assessed as continuous data to compare mean mRS, there was no significant difference between GTN and control (MD ‐0.08, 95% CI ‐0.52 to 0.36, I<sup>2</sup> = 47%, <a href="./references#CD000398-fig-0010" title="">Analysis 1.5</a>). </p> <section id="CD000398-sec-0066"> <h5 class="title">Stroke type</h5> <p>There was no differential effect by stroke type (<a href="./references#CD000398-fig-0007" title="">Analysis 1.2</a>; <a href="./references#CD000398-fig-0011" title="">Analysis 1.6</a>). </p> </section> <section id="CD000398-sec-0067"> <h5 class="title">Time to randomisation</h5> <p>Those participants randomised to GTN within six hours of stroke onset (two trials, 312 participants) had a tendency toward less death and dependency (OR 0.65, 95% CI 0.41 to 1.02; P = 0.06; I<sup>2</sup> = 0%). Randomisation at more than six hours after ictus did not influence the primary outcome and overall subgroup differences were nonsignificant (P = 0.28, <a href="./references#CD000398-fig-0008" title="">Analysis 1.3</a>). In the sensitivity analysis, mean mRS was lower in those randomised to GTN within six hours of onset as compared with control participants (MD ‐0.79, 95% CI ‐1.35 to ‐0.23; P = 0.005); an effect not seen in any other time period from randomisation although the interaction between time and mRS was significant (P = 0.05, <a href="./references#CD000398-fig-0012" title="">Analysis 1.7</a>). </p> </section> <section id="CD000398-sec-0068"> <h5 class="title">Baseline systolic BP</h5> <p>There was no differential effect by baseline systolic BP (<a href="./references#CD000398-fig-0009" title="">Analysis 1.4</a>; <a href="./references#CD000398-fig-0013" title="">Analysis 1.8</a>). </p> </section> </section> <section id="CD000398-sec-0069"> <h4 class="title">Death, end of treatment and end of trial</h4> <p>There was no significant treatment effect of GTN compared with control on death, whether measured early (<a href="./references#CD000398-fig-0014" title="">Analysis 1.9</a>) or end of trial (<a href="./references#CD000398-fig-0018" title="">Analysis 1.13</a>; 4197 participants; <a href="./full#CD000398-tbl-0001">summary of findings Table for the main comparison</a>). No significant differences were noted in any subgroups for death at end of treatment (<a href="./references#CD000398-fig-0015" title="">Analysis 1.10</a>; <a href="./references#CD000398-fig-0016" title="">Analysis 1.11</a>; <a href="./references#CD000398-fig-0017" title="">Analysis 1.12</a>), whilst death at end of trial was reduced in those randomised to GTN within six hours of stroke onset (OR 0.30, 95% CI 0.15 to 0.60; P = 0.0006; I<sup>2</sup> = 0%; <a href="./references#CD000398-fig-0020" title="">Analysis 1.15</a><i>),</i> with significant interaction between time and death (P = 0.01). </p> </section> <section id="CD000398-sec-0070"> <h4 class="title">Neurological deterioration, end of treatment</h4> <p>No significant difference was noted in early neurological deterioration between treatment and control (<a href="./references#CD000398-fig-0022" title="">Analysis 1.17</a>) in the four studies with data (4158 participants). Stroke type did not change the neutral effect seen overall (<a href="./references#CD000398-fig-0023" title="">Analysis 1.18</a>). Those randomised between 24 and 36 hours to GTN in one study (1218 participants; two studies were not estimable due to no events) had a higher likelihood of neurological deterioration than control participants (OR 2.00, 95% CI 1.19 to 3.35; P = 0.009). The other time groups revealed no difference between GTN and control (<a href="./references#CD000398-fig-0024" title="">Analysis 1.19</a>). Participants randomised to GTN with a baseline systolic BP of &lt; 160 mmHg (1688 participants) or 180 to 200 mmHg in two studies (743 participants; two studies were not estimable due to no events) were more likely to have neurological deterioration at end of treatment than controls (OR 1.62, 95% CI 1.05 to 2.50, P = 0.03 and OR 1.81, 95% CI 1.05 to 3.12, P = 0.03, respectively; <a href="./references#CD000398-fig-0025" title="">Analysis 1.20</a>). </p> </section> <section id="CD000398-sec-0071"> <h4 class="title">NIHSS, end of treatment</h4> <p>NIHSS was calculated using the SSS available from four trials (4137 participants). There was no significant difference between treatment and control (<a href="./references#CD000398-fig-0026" title="">Analysis 1.21</a>). Stroke type and baseline systolic BP had no influence on the neutral effect seen overall (<a href="./references#CD000398-fig-0027" title="">Analysis 1.22</a>; <a href="./references#CD000398-fig-0029" title="">Analysis 1.24</a>). Participants randomised to GTN within six hours of stroke onset had lower NIHSS scores at end of treatment compared with control (MD ‐2.07, 95% CI ‐3.81 to ‐0.34, P = 0.02), with no heterogeneity seen between the two trials, and significant interaction between time and NIHSS (P = 0.03, <a href="./references#CD000398-fig-0028" title="">Analysis 1.23</a>). </p> </section> <section id="CD000398-sec-0072"> <h4 class="title">Disability (Barthel Index), end of trial</h4> <p>Disability data in the form of BI was available for all five studies (4153 participants) with no significant difference detected between GTN and control (<a href="./references#CD000398-fig-0030" title="">Analysis 1.25</a>). Those randomised to GTN within six hours of stroke ictus (2 trials, 312 participants) had improved disability scores compared with control participants (MD 14.57, 95% CI 5.95 to 23.19, P = 0.0009), with no heterogeneity seen between the studies, and significant interaction between time and BI (P = 0.03, <a href="./references#CD000398-fig-0032" title="">Analysis 1.27</a>). Baseline systolic BP and stroke type subgroups had no associations of note for this outcome (<a href="./references#CD000398-fig-0031" title="">Analysis 1.26</a>; <a href="./references#CD000398-fig-0033" title="">Analysis 1.28</a>). </p> </section> <section id="CD000398-sec-0073"> <h4 class="title">Mood (Zung), end of trial</h4> <p>Mood was assessed in three studies (3312 participants) using the Zung depression scale (ZDS). No significant difference was seen between GTN and control (<a href="./references#CD000398-fig-0034" title="">Analysis 1.29</a>). Improved mood scores were seen in those randomised to GTN within six hours of the index event compared with control participants (MD ‐11.12, 95% CI ‐17.35 to ‐4.90, P = 0.0005) with no heterogeneity seen between the two studies (268 participants), and significant interaction between time and ZDS (P = 0.007, <a href="./references#CD000398-fig-0036" title="">Analysis 1.31</a>). Stroke type and baseline systolic BP had no associations of note for this outcome (<a href="./references#CD000398-fig-0035" title="">Analysis 1.30</a>; <a href="./references#CD000398-fig-0037" title="">Analysis 1.32</a>). </p> </section> <section id="CD000398-sec-0074"> <h4 class="title">Quality of life, end of trial</h4> <p>Two measures of quality of life were assessed: the EQ‐5D was transformed into a health utility status from data available in four studies (4088 participants); and the EQ‐VAS from four studies (3575 participants). There was no significant difference between treatment and control for either measure (<a href="./references#CD000398-fig-0038" title="">Analysis 1.33</a>; <a href="./references#CD000398-fig-0042" title="">Analysis 1.37</a>). Whilst the subgroups stroke type and baseline systolic BP had no impact on the neutral effect seen overall, early treatment with GTN within six hours of onset was associated with improved quality of life at day 90 compared with those randomised to control (EQ‐5D (2 trials, 312 participants) MD 0.11, 95% CI 0.02 to 0.20, P = 0.02, with minimal heterogeneity (I<sup>2</sup> = 3%; <a href="./references#CD000398-fig-0040" title="">Analysis 1.35</a>); and EQ‐VAS (2 trials, 295 participants) MD 9.96, 95% CI 2.49 to 17.43, P = 0.009 with no heterogeneity (<a href="./references#CD000398-fig-0044" title="">Analysis 1.39</a>)). Across time to randomisation, there was a significant interaction with EQ‐VAS (P = 0.04), but not EQ‐5D (P = 0.10). </p> </section> <section id="CD000398-sec-0075"> <h4 class="title">Cognition, end of trial</h4> <p>Three measures of cognition were assessed: three studies had t‐MMSE data (2078 participants, in two studies t‐MMSE was derived from MMSE); one study also used TICS and animal naming (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>). Overall, there was no significant difference between GTN and control (<a href="./references#CD000398-fig-0046" title="">Analysis 1.41</a>; <a href="./references#CD000398-fig-0050" title="">Analysis 1.45</a>; <a href="./references#CD000398-fig-0054" title="">Analysis 1.49</a>). Stroke type and baseline systolic BP did not influence this finding (<a href="./references#CD000398-fig-0047" title="">Analysis 1.42</a>; <a href="./references#CD000398-fig-0049" title="">Analysis 1.44</a>; <a href="./references#CD000398-fig-0051" title="">Analysis 1.46</a>; <a href="./references#CD000398-fig-0053" title="">Analysis 1.48</a>; <a href="./references#CD000398-fig-0055" title="">Analysis 1.50</a>; <a href="./references#CD000398-fig-0057" title="">Analysis 1.52</a>). Improved cognitive scores were seen across all three measures in those randomised to GTN within six hours of onset (t‐MMSE: MD 3.61, 95% CI 1.68 to 5.55, P = 0.0002 (2 trials, 219 participants, interaction P = 0.003; <a href="./references#CD000398-fig-0048" title="">Analysis 1.43</a>); TICS: MD 5.59, 95% CI 2.63 to 8.55, P = 0.0002 (1 trial, 182 participants, interaction P = 0.002; <a href="./references#CD000398-fig-0052" title="">Analysis 1.47</a>); and animal naming: MD 2.94, 95% CI 0.88 to 5.00, P = 0.005 (1 trial, 192 participants, interaction P = 0.04; <a href="./references#CD000398-fig-0056" title="">Analysis 1.51</a>)). </p> </section> <section id="CD000398-sec-0076"> <h4 class="title">Physiotherapy, occupational therapy, and speech and language therapy</h4> <p>Data on whether individuals received physiotherapy, occupational therapy or speech and language therapy during their admission were available from three studies (4042 participants). There was no difference between treatment groups in the rates of therapy required (<a href="./references#CD000398-fig-0058" title="">Analysis 1.53</a>; <a href="./references#CD000398-fig-0062" title="">Analysis 1.57</a>; <a href="./references#CD000398-fig-0066" title="">Analysis 1.61</a>). Rates of occupational therapy were lower, with borderline significance, in those randomised to GTN with baseline systolic BP level of 180.1 to 200 mmHg compared with control participants (OR 0.74, 95% CI 0.54 to 1.00, P = 0.05), with no heterogeneity seen between the three studies (730 participants), and higher in those randomised to GTN with baseline systolic BP &gt; 200 mmHg compared with controls (OR 2.11, 95% CI 1.25 to 3.54, P = 0.005), with no heterogeneity between the two studies (255 participants; <a href="./references#CD000398-fig-0065" title="">Analysis 1.60</a>). No other associations regarding baseline systolic BP were noted for rates of either physiotherapy (<a href="./references#CD000398-fig-0061" title="">Analysis 1.56</a>) or speech and language therapy (<a href="./references#CD000398-fig-0069" title="">Analysis 1.64</a>). Neither time to randomisation nor stroke type had any effect on therapy rates between treatment and control. </p> </section> <section id="CD000398-sec-0077"> <h4 class="title">Feeding route (non‐oral feeding at day 7)</h4> <p>Feeding route was recorded in three trials (4009 participants) and assessed as non‐oral feeding at day seven. Overall, there was no difference between GTN versus no GTN regarding rates of non‐oral feeding at day seven (<a href="./references#CD000398-fig-0070" title="">Analysis 1.65</a>). Early treatment with GTN within six hours of onset was associated with a nonsignificant tendency towards less non‐oral feeding (OR 0.59, 95% CI 0.32 to 1.08, P = 0.09), with no heterogeneity seen between the two studies (301 participants; <a href="./references#CD000398-fig-0072" title="">Analysis 1.67</a>). No associations of note were seen regarding other factors (time groups from randomisation, stroke type or baseline systolic BP (<a href="./references#CD000398-fig-0071" title="">Analysis 1.66</a>; <a href="./references#CD000398-fig-0073" title="">Analysis 1.68</a>)). </p> </section> <section id="CD000398-sec-0078"> <h4 class="title">Length of stay</h4> <p>The length of hospital stay relating to the index randomising event was assessed in four studies (4078 participants), with no significant treatment effect noted (<a href="./references#CD000398-fig-0074" title="">Analysis 1.69</a>). No subgroup effects were noted (<a href="./references#CD000398-fig-0075" title="">Analysis 1.70</a>; <a href="./references#CD000398-fig-0076" title="">Analysis 1.71</a>; <a href="./references#CD000398-fig-0077" title="">Analysis 1.72</a>). </p> </section> <section id="CD000398-sec-0079"> <h4 class="title">Headache on treatment</h4> <p>Headache on treatment was more common in people randomised to GTN than to control (OR 2.37, 95% CI 1.55 to 3.62; 4186 participants), with no significant heterogeneity seen (<a href="./references#CD000398-fig-0078" title="">Analysis 1.73</a>; <a href="./full#CD000398-tbl-0001">summary of findings Table for the main comparison</a>). GTN led to increased reporting of headache on treatment in both ischaemic stroke (OR 2.39, 95% CI 1.59 to 3.61, P &lt; 0.0001; 3409 participants; I<sup>2</sup> = 4%) and ICH (OR 1.91, 95% CI 1.24 to 2.93, P = 0.003; 639 participants; I<sup>2</sup> = 0%) compared with control (<a href="./references#CD000398-fig-0079" title="">Analysis 1.74</a>). Headache was more common in participants randomised to GTN than controls for all time periods of randomisation (<a href="./references#CD000398-fig-0080" title="">Analysis 1.75</a>) and all baseline systolic BP subgroups except &gt; 200 mmHg, which was neutral (<a href="./references#CD000398-fig-0081" title="">Analysis 1.76</a>). </p> </section> <section id="CD000398-sec-0080"> <h4 class="title">Treatment stopped early</h4> <p>There was no significant difference in the rate of treatment being stopped early between those randomised to GTN or control (4193 participants), although there was significant heterogeneity between trials (I<sup>2</sup> = 88%; <a href="./references#CD000398-fig-0082" title="">Analysis 1.77</a>). Treatment was more likely to be stopped in those randomised to GTN after six, and before 36, hours but these groups were dominated by <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a> (<a href="./references#CD000398-fig-0084" title="">Analysis 1.79</a>). Stroke type and baseline systolic BP did not alter the overall neutral effect seen. </p> </section> <section id="CD000398-sec-0081"> <h4 class="title">Haemodynamics</h4> <p>Haemodynamics are the first measurements on treatment (4197 participants; <a href="./full#CD000398-tbl-0001">summary of findings Table for the main comparison</a>; high‐quality evidence). BP (mmHg) was significantly lowered in those randomised to GTN compared with control (systolic BP: MD ‐7.21, 95% CI ‐8.58 to ‐5.85, <a href="./references#CD000398-fig-0086" title="">Analysis 1.81</a>; diastolic BP: MD ‐3.31, 95% CI ‐4.18 to ‐2.45, <a href="./references#CD000398-fig-0089" title="">Analysis 1.84</a>), whilst heart rate (beats per minute) was significantly increased (MD 2.02, 95% CI 1.13 to 2.91, <a href="./references#CD000398-fig-0092" title="">Analysis 1.87</a>). Of note, for heart rate there was significant heterogeneity (I<sup>2</sup> = 61%) between trials. Regardless of stroke type, BP was significantly lowered by GTN compared with control, and heart rate was increased (<a href="./references#CD000398-fig-0087" title="">Analysis 1.82</a>; <a href="./references#CD000398-fig-0090" title="">Analysis 1.85</a>; <a href="./references#CD000398-fig-0093" title="">Analysis 1.88</a>). BP was significantly lowered in those randomised to GTN compared with control in all time to randomisation groups (<a href="./references#CD000398-fig-0088" title="">Analysis 1.83</a>; <a href="./references#CD000398-fig-0091" title="">Analysis 1.86</a>), whilst heart rate was significantly increased in those randomised to GTN after 24, and before 36, hours (MD 3.44, 95% CI 1.79 to 5.09; 1218 participants; I<sup>2</sup> = 32%), with nonsignificant results seen in other time groups (<a href="./references#CD000398-fig-0094" title="">Analysis 1.89</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000398-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000398-sec-0082"></div> <section id="CD000398-sec-0083"> <h3 class="title" id="CD000398-sec-0083">Summary of main results</h3> <p>Five trials involving 4197 participants assessed transdermal GTN in acute stroke. Overall, GTN did not significantly influence clinical outcomes including death or disability, death, neurological deterioration, severity, mood, quality of life, cognition, length of hospital stay, therapy requirements, or feeding route. </p> <p>Subgroup analyses showed that participants randomised to GTN with baseline systolic BP &lt;160 or 180 to 200 mmHg had increased rates of neurological deterioration compared with controls. Conversely, receiving GTN with a baseline systolic BP 180 to 200 mmHg was associated with lower rates of occupational therapy but higher rates were seen with a baseline systolic BP &gt; 200 mmHg. There were no consistent effects across outcomes regarding baseline systolic BP. Participants randomised to GTN within six hours of symptom onset had nonsignificant reductions in the rates of death or dependency (mRS &gt; 2) and non‐oral feeding, and significant improvements in NIHSS at end of treatment, and death or dependency (mean mRS), death, disability, mood, quality of life, and cognition at end of trial. Although participants randomised to GTN between 24 and 36 hours after stroke onset had an increased chance of neurological deterioration, no significant findings were noted in any other clinical outcomes for this time period. Some of the heterogeneity seen between the trials for several outcomes may relate to the differing times from stroke onset to randomisation, which ranged from within four hours of onset up to 168 hours from onset. </p> <p>In respect of haemodynamics, BP was significantly lowered by GTN as compared with control regardless of stroke type and time to randomisation, whilst heart rate was significantly increased overall, regardless of stroke type, and in those randomised between 24 and 36 hours after stroke onset. Headache, a recognised side effect of GTN, was more commonly seen in those randomised to GTN overall, in both stroke types, at all times of randomisation and in all but those with baseline systolic BP &gt; 200 mmHg. </p> <p>Of note, there was no significant difference in the rate of treatment being stopped early between GTN and control but there was significant heterogeneity between the trials. Those who received GTN between six and 36 hours of stroke onset were more likely to stop treatment early; a finding driven by ENOS (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>). </p> </section> <section id="CD000398-sec-0084"> <h3 class="title" id="CD000398-sec-0084">Overall completeness and applicability of evidence</h3> <p>This review includes all identified trials of NO donors in people with recent stroke. All five trials studied transdermal GTN and no RCTs assessing other NO donors, L‐arginine or nitric oxide synthase inhibitors have been completed. The results from trials assessing GTN should not be extrapolated to other NO donors, L‐arginine or nitric oxide synthase inhibitors. With 4197 participants across five trials, this review has substantial external validity and is able to comment on the safety and efficacy of GTN in acute stroke. Overall, GTN was safe, lowered BP and increased heart rate, but had no beneficial effect on primary and secondary clinical outcomes. </p> <p>The potential benefit of GTN seen in participants randomised within six hours of onset may represent chance, but there are several explanations to suggest that the association could be real. </p> <p> <ol id="CD000398-list-0011"> <li> <p>The beneficial effects seen were across multiple outcomes including death, dependency (mRS), disability (BI), mood (ZDS), NIHSS, quality of life (EQ‐5D health utility status and EQ‐VAS) and cognition (t‐MMSE, TICS, animal naming). </p> </li> <li> <p>The effects were seen in two separate trials (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>). </p> </li> <li> <p>The effects were seen in a population of over 300 participants. This group is equivalent in size to each of the parts of the positive NINDS trials of intravenous alteplase (<a href="./references#CD000398-bbs2-0060" title="National Institute of Neurological Disorders and Stroke rt‐PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine1995;333(24):1581‐7. ">NINDS 1995</a>) and recent trials of mechanical thrombectomy (<a href="./references#CD000398-bbs2-0040" title="GoyalM , MenonBK , VanZwamWH , DippelDWJ , MitchellPJ , DemchukAM , the HERMES Collaborators. Endovascular thrombectomy after large‐vessel ischaemic stroke: a meta‐analysis of individual patient data from five randomised trials. Lancet2016;387(10029):1723‐31. ">Goyal 2016</a>). </p> </li> <li> <p>The time‐dependent effect of NO donors has been demonstrated in a meta‐analysis of pre‐clinical studies in which early treatment within 60 minutes of ischaemia was associated with positive outcomes as compared with neutral outcomes in those studies assessing treatment up to 48 hours following induction of ischaemic stroke (<a href="./references#CD000398-bbs2-0082" title="WillmotM , GrayL , GibsonC , MurphyS , BathPMW . A systematic review of nitric oxide donors and L‐arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide2005;12(3):141‐9. ">Willmot 2005</a>). </p> </li> </ol> </p> <p>Hyperacute administration of NO donors, such as GTN, has several potential mechanisms of action alluded to in the background of this review. </p> <p> <ol id="CD000398-list-0012"> <li> <p>NO levels are low in acute stroke and replacing this deficiency may be beneficial.</p> </li> <li> <p>NO donors lower BP, pulse pressure and peak systolic BP, and improve arterial compliance. Lowering BP acutely may reduce early recurrence following ischaemic stroke, and haematoma expansion in ICH (<a href="./references#CD000398-bbs2-0023" title="AndersonCS , HeeleyE , HuangY , WangJ , StapfC , DelcourtC , INTERACT2 Investigators. Rapid blood‐pressure lowering in patients with acute intracerebral hemorrhage. New England Journal of Medicine2013;368(25):2355‐65. ">Anderson 2013</a>). </p> </li> <li> <p>NO dilates cerebral arteries thereby increasing perilesional perfusion through the 'front door' without resultant cerebral steal (<a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). </p> </li> <li> <p>NO is a potent vasodilator of pial arteries leading to 'back‐door' collateral reperfusion (<a href="./references#CD000398-bbs2-0057" title="MorikawaE , RosenblattS , MoskowitzMA . L‐arginine dilates rat pial arterioles by nitric oxide‐dependent mechanisms and increases blood flow during focal cerebral ischaemia. British Journal of Pharmacology1992;107(4):905‐7. ">Morikawa 1992b</a>). </p> </li> <li> <p>NO donors are neuroprotective when administered early after preclinical ischaemic stroke (<a href="./references#CD000398-bbs2-0082" title="WillmotM , GrayL , GibsonC , MurphyS , BathPMW . A systematic review of nitric oxide donors and L‐arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide2005;12(3):141‐9. ">Willmot 2005</a>). </p> </li> <li> <p>NO donors might augment the effects of established interventions such as intravenous alteplase, both through preparing patients for treatment by lowering BP, and potentially by increasing access of lytics to occluding clot. </p> </li> </ol> </p> </section> <section id="CD000398-sec-0085"> <h3 class="title" id="CD000398-sec-0085">Quality of the evidence</h3> <p>This review has several strengths.</p> <p> <ol id="CD000398-list-0013"> <li> <p>The study cohort was large, involving more than 4000 participants.</p> </li> <li> <p>Individual patient data were used from all identified controlled trials of NO donors, facilitating subgroup analyses. </p> </li> <li> <p>Differing participant characteristics between trials broadened external validity.</p> </li> <li> <p>The trials examined different time‐windows after stroke onset including ultra‐acute/pre‐hospital (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>), hyper‐acute (&lt; 6 hours) (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>), acute (&lt; 48 hours) (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>), and sub‐acute (&lt; 168 hours) (<a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>; <a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>). </p> </li> <li> <p>Safety and efficacy were assessed across a multitude of outcomes encompassing multiple clinical domains; similar results across outcome domains and trials suggest intra‐ and inter‐trial consistency. </p> </li> </ol> </p> <p>There are also several limitations of this review.</p> <p> <ol id="CD000398-list-0014"> <li> <p>GTN was the only NO donor assessed in the included RCTs and therefore the results cannot be extrapolated to other NO donors, for which there is no RCT‐based evidence. </p> </li> <li> <p><a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a> accounted for 95.6% of all participants included in this review, and therefore dominated the data and subsequent analyses. </p> </li> <li> <p>All these data were reported by the same research group and therefore the results need to be validated and extended by other research groups. </p> </li> <li> <p>Only one of the included studies was double‐blind (<a href="./references#CD000398-bbs2-0002" title="BathPMW , PathansaliR , IddendenR , BathFJ . The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases1999;9 Suppl 1:101. BathPMW , PathansaliR , IddendenR , BathFJ . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases2001;11:265‐72. ">Bath 2001</a>), with the remainder being single‐blind (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>; <a href="./references#CD000398-bbs2-0005" title="WillmotM , GhadamiA , WhysallB , ClarkeW , WardlawJ , BathPMW . Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006;47:1209‐15. ">Willmot 2006</a>) or open‐label (<a href="./references#CD000398-bbs2-0004" title="RashidPA , Leonardi‐BeeJA , WeaverCS , BathFJ , BathPM . The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and middle cerebral artery blood velocity in acute stroke. Stroke2002;33:383. RashidPA , WeaverC , Leonardi‐BeeJA , BathFJ , FletcherS , BathPMW . The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases2003;12(3):143‐51. ">Rashid 2002</a>). Further, headache, a common side effect of GTN, may have unblinded some participants. In addition, despite all end‐of‐trial outcome measures being performed by assessors blinded to treatment in the included studies, observer bias cannot be excluded. </p> </li> <li> <p>The results relating to ultra‐acute and hyper‐acute treatment involved a relatively small number of participants (<a href="./references#CD000398-bbs2-0001" title='AnkolekarS , FullerM , CrossI , RentonC , CoxP , SpriggN , et al. Feasibility of an ambulance‐based stroke trial, and safety of glyceryl trinitrate in ultra‐acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). Stroke2013;44:3120‐8. [ISRCTN66434824] AnkolekarS , ParryR , SpriggN , SiriwardenaAN , BathPMW . Views of paramedics on their role in an out‐of‐hospital ambulance‐based trial in ultra‐acute stroke: qualitative data from the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial (RIGHT). Annals of Emergency Medicine2014;64(6):640‐8. AnkolekarS , SareG , GeeganageC , FullerM , StokesL , SpriggN , et al. Determining the feasibility of ambulance‐based randomised controlled trials in patients with ultra‐acute stroke: study protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT). Stroke Research and Treatment2012;2012:385753. [ISRCTN66434824] '>Ankolekar 2013</a>; <a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>); these findings should be considered provisional and require formal testing. </p> </li> <li> <p>This review contains analyses involving a variety of outcomes assessed in several subgroups. Such multiple testing can lead to spurious results and it is possible that some findings may simply reflect chance, e.g. increased neurological deterioration in certain BP subgroups (in the absence of a trend across BP, or a negative effect on the NIHSS), or variation in occupational therapy utilisation in BP subgroups. </p> </li> </ol> </p> <p>In summary, the overall quality of the evidence as assessed by GRADE criteria was high, due to the aforementioned strengths of the included studies. </p> </section> <section id="CD000398-sec-0086"> <h3 class="title" id="CD000398-sec-0086">Potential biases in the review process</h3> <p>This review was compiled following an extensive literature search, without language restrictions, by both the review authors and Cochrane Stroke Group. The resultant risk for publication bias is therefore low. However, all the included trials were from the same research group ‐ of which the authors are members ‐ which may have potentially introduced bias in the review process, e.g. in choice of outcomes and subgroups. Nevertheless, all outcomes reported in the included trials were summarised here (including mRS, BI, EQ‐5D, EQ‐VAS, t‐MMSE, TICS‐M, animal naming, ZDS, NIHSS, death), and subgroups (time, stroke type, blood pressure) were used as prespecified in the ENOS trial (<a href="./references#CD000398-bbs2-0003" title="BathPMW , HoultonA , WoodhouseL , SpriggN , WardlawJ , PocockS , the ENOS Trialists. Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:372‐4. ENOS Investigators. Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. International Journal of Stroke2014;9:711‐20. The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial‐factorial randomised controlled trial. Lancet2015;385:617‐28. The ENOS Trial Investigators. Glyceryl trinitrate vs control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial. International Journal of Stroke2006;1:245‐9. [ISRCTN99414122] ">ENOS 2015</a>). </p> </section> <section id="CD000398-sec-0087"> <h3 class="title" id="CD000398-sec-0087">Agreements and disagreements with other studies or reviews</h3> <p>A recently published systematic review and individual patient data meta‐analysis assessed the same five trials of transdermal GTN under the auspices of the Blood pressure in Acute Stroke Collaboration (<a href="./references#CD000398-bbs2-0026" title="BathPM , WoodhouseL , KrishnanK , AndersonC , BergeE , FordGA , Blood pressure in Acute Stroke Collaboration (BASC). Effect of treatment delay, stroke type, and thrombolysis on the effect of glyceryl trinitrate, a nitric oxide donor, on outcome after acute stroke: a systematic review and meta‐analysis of individual patient from randomised trials. Stroke Research and Treatment2016;2016:1‐12. [DOI: 10.1155/2016/9706720] ">BASC 2016</a>). Both unadjusted and adjusted analyses were performed including a predefined subgroup analysis by time to randomisation. In this regard, the results and conclusions of both reviews were similar showing that GTN is safe though ineffective overall, but may improve outcome in a time‐dependent manner if given within six hours of stroke onset. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000398-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Results of Database Search" data-id="CD000398-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Results of Database Search</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD000398-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000398-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome: 1.1 Death or dependency (mRS&gt;2), end of trial." data-id="CD000398-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome: 1.1 Death or dependency (mRS&gt;2), end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, outcome: 1.81 Systolic BP, first treatment measurement." data-id="CD000398-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, outcome: 1.81 Systolic BP, first treatment measurement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 1 Death or dependency (mRS&gt;2), end of trial." data-id="CD000398-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 1 Death or dependency (mRS&gt;2), end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 2 Death or dependency (mRS&gt;2), end of trial, by stroke type." data-id="CD000398-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 2 Death or dependency (mRS&gt;2), end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 3 Death or dependency (mRS&gt;2), end of trial, by time to randomisation." data-id="CD000398-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 3 Death or dependency (mRS&gt;2), end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 4 Death or dependency (mRS&gt;2), end of trial, by baseline SBP." data-id="CD000398-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 4 Death or dependency (mRS&gt;2), end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 5 Death or dependency (mean mRS), end of trial." data-id="CD000398-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 5 Death or dependency (mean mRS), end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 6 Death or dependency (mean mRS), end of trial, by stroke type." data-id="CD000398-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 6 Death or dependency (mean mRS), end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 7 Death or dependency (mean mRS), end of trial, by time to randomisation." data-id="CD000398-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 7 Death or dependency (mean mRS), end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 8 Death or dependency (mean mRS), end of trial, by baseline SBP." data-id="CD000398-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 8 Death or dependency (mean mRS), end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 9 Death, end of treatment." data-id="CD000398-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 9 Death, end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 10 Death, end of treatment, by stroke type." data-id="CD000398-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 10 Death, end of treatment, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 11 Death, end of treatment, by time to randomisation." data-id="CD000398-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 11 Death, end of treatment, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 12 Death, end of treatment, by baseline SBP." data-id="CD000398-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 12 Death, end of treatment, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 13 Death, end of trial." data-id="CD000398-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 13 Death, end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 14 Death, end of trial, by stroke type." data-id="CD000398-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 14 Death, end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 15 Death, end of trial, by time to randomisation." data-id="CD000398-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 15 Death, end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 16 Death, end of trial, by baseline SBP." data-id="CD000398-fig-0021" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 16 Death, end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 17 Neurological deterioration, end of treatment." data-id="CD000398-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 17 Neurological deterioration, end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 18 Neurological deterioration, end of treatment, by stroke type." data-id="CD000398-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 18 Neurological deterioration, end of treatment, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 19 Neurological deterioration, end of treatment, by time to randomisation." data-id="CD000398-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 19 Neurological deterioration, end of treatment, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 20 Neurological deterioration, end of treatment, by baseline SBP." data-id="CD000398-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 20 Neurological deterioration, end of treatment, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 21 NIH Stroke Scale, end of treatment." data-id="CD000398-fig-0026" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 21 NIH Stroke Scale, end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 22 NIH Stroke Scale, end of treatment, by stroke type." data-id="CD000398-fig-0027" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 22 NIH Stroke Scale, end of treatment, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 23 NIH Stroke Scale, end of treatment, by time to randomisation." data-id="CD000398-fig-0028" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 23 NIH Stroke Scale, end of treatment, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 24 NIH Stroke Scale, end of treatment, by baseline SBP." data-id="CD000398-fig-0029" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 24 NIH Stroke Scale, end of treatment, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 25 Barthel Index, end of trial." data-id="CD000398-fig-0030" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 25 Barthel Index, end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 26 Barthel Index, end of trial, by stroke type." data-id="CD000398-fig-0031" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 26 Barthel Index, end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 27 Barthel Index, end of trial, by time to randomisation." data-id="CD000398-fig-0032" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 27 Barthel Index, end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 28 Barthel Index, end of trial, by baseline SBP." data-id="CD000398-fig-0033" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 28 Barthel Index, end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 29 Mood (Zung), end of trial." data-id="CD000398-fig-0034" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 29 Mood (Zung), end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 30 Mood (Zung), end of trial, by stroke type." data-id="CD000398-fig-0035" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 30 Mood (Zung), end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 31 Mood (Zung), end of trial, by time to randomisation." data-id="CD000398-fig-0036" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 31 Mood (Zung), end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 32 Mood (Zung), end of trial, by baseline SBP." data-id="CD000398-fig-0037" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 32 Mood (Zung), end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 33 EQ5D‐3L, end of trial." data-id="CD000398-fig-0038" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 33 EQ5D‐3L, end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 34 EQ5D‐3L, end of trial, by stroke type." data-id="CD000398-fig-0039" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 34 EQ5D‐3L, end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 35 EQ5D‐3L, end of trial, by time to randomisation." data-id="CD000398-fig-0040" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 35 EQ5D‐3L, end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 36 EQ5D‐3L, end of trial, by baseline SBP." data-id="CD000398-fig-0041" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 36 EQ5D‐3L, end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 37 EQ VAS, end of trial." data-id="CD000398-fig-0042" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 37 EQ VAS, end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 38 EQ VAS, end of trial, by stroke type." data-id="CD000398-fig-0043" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 38 EQ VAS, end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 39 EQ VAS, end of trial, by time to randomisation." data-id="CD000398-fig-0044" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 39 EQ VAS, end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 40 EQ VAS, end of trial, by baseline SBP." data-id="CD000398-fig-0045" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 40 EQ VAS, end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 41 t‐MMSE, end of trial." data-id="CD000398-fig-0046" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 41 t‐MMSE, end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 42 t‐MMSE, end of trial, by stroke type." data-id="CD000398-fig-0047" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 42 t‐MMSE, end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 43 t‐MMSE, end of trial, by time to randomisation." data-id="CD000398-fig-0048" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 43 t‐MMSE, end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 44 t‐MMSE, end of trial, by baseline SBP." data-id="CD000398-fig-0049" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 44 t‐MMSE, end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 45 TICS, end of trial." data-id="CD000398-fig-0050" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 45 TICS, end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 46 TICS, end of trial, by stroke type." data-id="CD000398-fig-0051" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 46 TICS, end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-47" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-47.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 47 TICS, end of trial, by time to randomisation." data-id="CD000398-fig-0052" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-47.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.47</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 47 TICS, end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-47.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 48 TICS, end of trial, by baseline SBP." data-id="CD000398-fig-0053" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.48</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 48 TICS, end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-48.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-49" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-49.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 49 Animal naming, end of trial." data-id="CD000398-fig-0054" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-49.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.49</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 49 Animal naming, end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-49.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-50" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-50.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 50 Animal naming, end of trial, by stroke type." data-id="CD000398-fig-0055" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-50.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.50</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 50 Animal naming, end of trial, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-50.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-51" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-51.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 51 Animal naming, end of trial, by time to randomisation." data-id="CD000398-fig-0056" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-51.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.51</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 51 Animal naming, end of trial, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-51.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-52" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-52.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 52 Animal naming, end of trial, by baseline SBP." data-id="CD000398-fig-0057" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-52.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.52</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 52 Animal naming, end of trial, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-52.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-53" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-53.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 53 Physiotherapy." data-id="CD000398-fig-0058" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-53.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.53</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 53 Physiotherapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-53.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-54" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-54.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 54 Physiotherapy, by stroke type." data-id="CD000398-fig-0059" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-54.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.54</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 54 Physiotherapy, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-54.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-55" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-55.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 55 Physiotherapy, by time to randomisation." data-id="CD000398-fig-0060" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-55.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.55</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 55 Physiotherapy, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-55.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-56" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-56.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 56 Physiotherapy, by baseline SBP." data-id="CD000398-fig-0061" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-56.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.56</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 56 Physiotherapy, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-56.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-57" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-57.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 57 Occupational therapy." data-id="CD000398-fig-0062" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-57.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.57</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 57 Occupational therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-57.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-58" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-58.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 58 Occupational therapy, by stroke type." data-id="CD000398-fig-0063" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-58.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.58</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 58 Occupational therapy, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-58.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-59" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-59.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 59 Occupational therapy, by time to randomisation." data-id="CD000398-fig-0064" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-59.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.59</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 59 Occupational therapy, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-59.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-60" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-60.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 60 Occupational therapy, by baseline SBP." data-id="CD000398-fig-0065" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-60.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.60</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 60 Occupational therapy, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-60.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-61" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-61.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 61 Speech and language therapy." data-id="CD000398-fig-0066" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-61.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.61</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 61 Speech and language therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-61.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-62" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-62.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 62 Speech and language therapy, by stroke type." data-id="CD000398-fig-0067" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-62.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.62</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 62 Speech and language therapy, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-62.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-63" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-63.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 63 Speech and language therapy, by time to randomisation." data-id="CD000398-fig-0068" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-63.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.63</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 63 Speech and language therapy, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-63.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-64" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-64.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 64 Speech and language therapy, by baseline SBP." data-id="CD000398-fig-0069" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-64.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.64</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 64 Speech and language therapy, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-64.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-65" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-65.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 65 Feeding route (non‐oral feeding at day 7)." data-id="CD000398-fig-0070" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-65.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.65</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 65 Feeding route (non‐oral feeding at day 7). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-65.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-66" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-66.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 66 Feeding route (non‐oral feeding at day 7), by stroke type." data-id="CD000398-fig-0071" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-66.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.66</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 66 Feeding route (non‐oral feeding at day 7), by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-66.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-67" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-67.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 67 Feeding route (non‐oral feeding at day 7), by time to randomisation." data-id="CD000398-fig-0072" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-67.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.67</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 67 Feeding route (non‐oral feeding at day 7), by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-67.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-68" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-68.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 68 Feeding route (non‐oral feeding at day 7), by baseline SBP." data-id="CD000398-fig-0073" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-68.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.68</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 68 Feeding route (non‐oral feeding at day 7), by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-68.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-69" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-69.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 69 Length of stay." data-id="CD000398-fig-0074" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-69.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.69</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 69 Length of stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-69.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-70" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-70.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 70 Length of stay, by stroke type." data-id="CD000398-fig-0075" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-70.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.70</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 70 Length of stay, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-70.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-71" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-71.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 71 Length of stay by time, to randomisation." data-id="CD000398-fig-0076" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-71.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.71</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 71 Length of stay by time, to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-71.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-72" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-72.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 72 Length of stay, by baseline SBP." data-id="CD000398-fig-0077" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-72.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.72</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 72 Length of stay, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-72.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-73" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-73.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 73 Headache, on treatment." data-id="CD000398-fig-0078" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-73.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.73</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 73 Headache, on treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-73.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-74" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-74.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 74 Headache, on treatment, by stroke type." data-id="CD000398-fig-0079" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-74.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.74</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 74 Headache, on treatment, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-74.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-75" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-75.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 75 Headache, on treatment, by time to randomisation." data-id="CD000398-fig-0080" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-75.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.75</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 75 Headache, on treatment, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-75.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-76" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-76.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 76 Headache, on treatment, by baseline SBP." data-id="CD000398-fig-0081" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-76.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.76</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 76 Headache, on treatment, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-76.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-77" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-77.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 77 Treatment stopped early." data-id="CD000398-fig-0082" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-77.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.77</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 77 Treatment stopped early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-77.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-78" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-78.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 78 Treatment stopped early, by stroke type." data-id="CD000398-fig-0083" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-78.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.78</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 78 Treatment stopped early, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-78.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-79" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-79.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 79 Treatment stopped early, by time to randomisation." data-id="CD000398-fig-0084" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-79.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.79</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 79 Treatment stopped early, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-79.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-80" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-80.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 80 Treatment stopped early, by baseline SBP." data-id="CD000398-fig-0085" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-80.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.80</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 80 Treatment stopped early, by baseline SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-80.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-81" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-81.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 81 Systolic BP, first treatment measurement." data-id="CD000398-fig-0086" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-81.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.81</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 81 Systolic BP, first treatment measurement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-81.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-82" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-82.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 82 Systolic BP, first treatment measurement, by stroke type." data-id="CD000398-fig-0087" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-82.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.82</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 82 Systolic BP, first treatment measurement, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-82.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-83" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-83.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 83 Systolic BP, first treatment measurement, by time to randomisation." data-id="CD000398-fig-0088" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-83.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.83</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 83 Systolic BP, first treatment measurement, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-83.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-84" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-84.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 84 Diastolic BP, first treatment measurement." data-id="CD000398-fig-0089" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-84.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.84</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 84 Diastolic BP, first treatment measurement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-84.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-85" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-85.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 85 Diastolic BP, first treatment measurement, by stroke type." data-id="CD000398-fig-0090" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-85.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.85</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 85 Diastolic BP, first treatment measurement, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-85.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-86" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-86.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 86 Diastolic BP, first treatment measurement, by time to randomisation." data-id="CD000398-fig-0091" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-86.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.86</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 86 Diastolic BP, first treatment measurement, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-86.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-87" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-87.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 87 Heart rate, first treatment measurement." data-id="CD000398-fig-0092" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-87.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.87</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 87 Heart rate, first treatment measurement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-87.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-88" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-88.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 88 Heart rate, first treatment measurement, by stroke type." data-id="CD000398-fig-0093" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-88.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.88</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 88 Heart rate, first treatment measurement, by stroke type. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-88.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000398-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/urn:x-wiley:14651858:media:CD000398:CD000398-CMP-001-89" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_t/tCD000398-CMP-001-89.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 89 Heart rate, first treatment measurement, by time to randomisation." data-id="CD000398-fig-0094" src="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-89.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.89</div> <div class="figure-caption"> <p>Comparison 1 Glyceryl trinitrate (GTN) compared with no GTN for acute stroke, Outcome 89 Heart rate, first treatment measurement, by time to randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/media/CDSR/CD000398/image_n/nCD000398-CMP-001-89.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000398-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: people with acute stroke</b> </p> <p><b>Settings: pre‐hospital / hospital</b> </p> <p><b>Intervention: GTN</b> </p> <p><b>Comparison: no GTN</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Anticipated absolute effects (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with no GTN / placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with GTN compared with no GTN for acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or dependency (mRS&gt;2), end of trial (90 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>609 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>601 per 1,000</b> <br/> (573 to 631) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.97</b> </p> <p>(0.86 to 1.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4195 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death, end of trial (90 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>131 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>115 per 1,000</b> <br/> (90 to 184) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.78</b> <br/> (0.40 to 1.50) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life, end of trial (90 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life (EQ‐5D3L), end of trial ranged across control groups from 0.25 to 0.9. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean quality of life (EQ‐5D3L), end of trial in the intervention group was <b>0.01 lower (0.17 lower to 0.15 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4088 <br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health utility status derived from European Quality of life‐5 dimensions‐3 levels (EQ‐5D3L). Significant heterogeneity between trials (I<sup>2</sup> = 78%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Systolic BP, first treatment measurement (&lt;24 hours after randomisation)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean systolic BP, first treatment measurement ranged across control groups from 151.13 to 185.17 mmHg. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean systolic BP, first treatment measurement in the intervention group was <b>7.21 mmHg lower (8.58 lower to 5.85 lower)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diastolic BP, first treatment measurement (&lt;24 hours after randomisation)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean diastolic BP, first treatment measurement ranged across control groups from 82.34 to 91.0 mmHg. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean diastolic BP, first treatment measurement in the intervention group was <b>3.31 mmHg lower (4.18 lower to 2.45 lower)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197<br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Heart rate, first treatment measurement (&lt;24 hours after randomisation)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean heart rate, first treatment measurement ranged across control groups from 65.5 to 77.27 beats per minute. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean heart rate, first treatment measurement in the intervention group was <b>2.02 beats per minute higher (1.13 higher to 2.91 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4197 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant heterogeneity between trials (I<sup>2</sup> = 61%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Headache, on treatment (7‐12 days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>84 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>180 per 1,000</b> </p> <p>(125 to 250)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 2.37</b> <br/> (1.55 to 3.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4186 <br/> (5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>BP: blood pressure; CI: confidence interval; GTN: glyceryl trinitrate; MD: mean difference; OR: odds ratio </p> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/full#CD000398-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000398-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death or dependency (mRS&gt;2), end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death or dependency (mRS&gt;2), end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.81, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.62, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Intracerebral haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.45, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death or dependency (mRS&gt;2), end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.41, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.83, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.76, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.83, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.72, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Death or dependency (mRS&gt;2), end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.85, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.82, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.23, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>747</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.70, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Death or dependency (mean mRS), end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.52, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.52, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Death or dependency (mean mRS), end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.31, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.62, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.24, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Death or dependency (mean mRS), end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.27, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.35, ‐0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [‐0.15, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.24, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.13, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.35, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Death or dependency (mean mRS), end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.26, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 &lt;160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.16, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 160.1‐180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐1.42, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 180.1‐200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>747</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.20, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 &gt;200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.70, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Death, end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.76, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.76, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Death, end of treatment, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.73, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.69, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.50, 2.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Death, end of treatment, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.74, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.28, 2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.49, 5.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.46, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.90 [0.90, 4.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.35, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Death, end of treatment, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.76, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.83, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 160.1‐180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.47, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.28, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.13 [0.60, 7.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Death, end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.40, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.40, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Death, end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.72, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.69, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.22, 5.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Death, end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.58, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.15, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.79, 2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.20, 11.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.69, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.27, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Death, end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.72, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.71, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.44, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.54, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.40, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Neurological deterioration, end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.97, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.97, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Neurological deterioration, end of treatment, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.74, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.09, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>637</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.83, 2.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Neurological deterioration, end of treatment, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.81, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.28, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.93, 4.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.74, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.19, 3.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.55, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Neurological deterioration, end of treatment, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.88, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Baseline SBP &lt; 160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [1.05, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 Baseline SBP 160.1 to 180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.58, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3 Baseline SBP 180.1 to 200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>743</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [1.05, 3.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.4 Baseline SBP &gt; 200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.25, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 NIH Stroke Scale, end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.70, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.70, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 NIH Stroke Scale, end of treatment, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4085</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐1.19, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐2.39, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>633</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.94, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 NIH Stroke Scale, end of treatment, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.88, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.07 [‐3.81, ‐0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [‐0.14, 2.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.3 12.1‐24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1062</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐1.13, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.81, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐1.50, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 NIH Stroke Scale, end of treatment, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.65, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1681</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐1.04, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐2.32, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐1.05, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [‐1.46, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Barthel Index, end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐5.39, 5.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐5.39, 5.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Barthel Index, end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [‐3.72, 4.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐5.27, 6.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>634</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [‐5.19, 7.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Barthel Index, end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [‐1.62, 5.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.57 [5.95, 23.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.47 [‐11.00, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1057</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [‐3.21, 6.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [‐3.81, 4.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐4.88, 5.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Barthel Index, end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [‐3.00, 4.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1687</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [‐2.89, 3.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.30 [‐8.25, 16.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [‐5.36, 5.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.74 [‐2.49, 17.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Mood (Zung), end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.83 [‐4.44, 2.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.83 [‐4.44, 2.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Mood (Zung), end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3269</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐2.20, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2745</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐7.81, 5.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>524</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [‐3.67, 4.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Mood (Zung), end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐4.38, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.12 [‐17.35, ‐4.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [‐2.58, 7.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [‐2.34, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [‐2.58, 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>848</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.54 [‐4.66, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Mood (Zung), end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐2.06, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [‐9.36, 11.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐3.09, 2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>582</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐4.07, 3.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.32 [‐11.37, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 EQ5D‐3L, end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4088</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.17, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4088</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.17, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 EQ5D‐3L, end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4084</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.08, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.17, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.08, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 EQ5D‐3L, end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4087</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.02, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.12, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1052</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.06, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1092</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.33, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 EQ5D‐3L, end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4086</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.05, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1664</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.34, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1438</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.08, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>726</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.07, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.01, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 EQ VAS, end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [‐0.91, 3.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>37.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [‐0.91, 3.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 EQ VAS, end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [‐1.13, 2.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2974</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [‐1.06, 3.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.43 [‐5.72, 4.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 EQ VAS, end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3574</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.91 [‐1.21, 5.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.96 [2.49, 17.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.92 [‐9.45, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>906</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [‐3.42, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1045</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.56 [‐5.31, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.63 [‐1.21, 10.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 EQ VAS, end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3574</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [‐1.16, 2.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [‐2.74, 3.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [‐6.59, 10.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [‐4.21, 5.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>40.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.22 [‐3.55, 14.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 t‐MMSE, end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [‐1.77, 4.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>41.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [‐1.77, 4.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 t‐MMSE, end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [‐0.90, 2.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1729</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [‐3.44, 9.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>42.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐1.61, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 t‐MMSE, end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [‐0.59, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.61 [1.68, 5.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.75 [‐3.68, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.3 12.1 to ‐24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>556</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐1.24, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [‐0.90, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [‐0.58, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 t‐MMSE, end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2073</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐0.46, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>860</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.21, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>744</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.78 [‐4.78, 14.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐1.56, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [‐1.49, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 TICS, end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.63, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.63, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 TICS, end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐0.59, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1683</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [‐0.59, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐2.65, 2.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 TICS, end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [‐1.33, 2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.59 [2.63, 8.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.19 [‐4.94, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.56 [‐2.32, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐1.46, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>47.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [‐1.32, 2.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 TICS, end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.76, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>838</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐2.11, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>728</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [‐0.21, 2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐2.20, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>48.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [‐1.00, 5.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49 Animal naming, end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.53, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>49.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.53, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50 Animal naming, end of trial, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.51, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>50.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.60, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>50.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [‐1.25, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51 Animal naming, end of trial, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.80, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>51.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.94 [0.88, 5.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>51.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐3.26, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>51.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐1.21, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>51.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐1.48, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>51.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>568</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [‐0.82, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52 Animal naming, end of trial, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.53, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>52.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>966</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐1.36, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>52.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>850</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.64, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>52.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐1.25, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>52.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [‐1.69, 3.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">53 Physiotherapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.79, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>53.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.79, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">54 Physiotherapy, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.80, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>54.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.74, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>54.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.79, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">55 Physiotherapy, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.80, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>55.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.40, 2.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>55.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.56, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>55.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.77, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>55.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.76, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>55.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.54, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">56 Physiotherapy, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.78, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1624</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.75, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.46, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.44, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>56.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [0.54, 5.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">57 Occupational therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.72, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>57.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.72, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">58 Occupational therapy, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.84, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>58.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.81, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>58.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.92, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">59 Occupational therapy, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>59.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.36, 3.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>59.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.65, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>59.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.82, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>59.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.79, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>59.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.72, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">60 Occupational therapy, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.81, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>60.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1624</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.81, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>60.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.76, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>60.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.54, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>60.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.25, 3.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">61 Speech and language therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>61.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">62 Speech and language therapy, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.85, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>62.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>62.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.14, 4.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">63 Speech and language therapy, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.85, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.44, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.64, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.75, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.76, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>63.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.79, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">64 Speech and language therapy, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4042</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>64.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1624</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.58, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>64.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.76, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>64.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.75, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>64.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.84, 2.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">65 Feeding route (non‐oral feeding at day 7) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>65.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">66 Feeding route (non‐oral feeding at day 7), by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3962</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.80, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>66.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.75, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>66.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>623</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.88, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">67 Feeding route (non‐oral feeding at day 7), by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>67.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.32, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>67.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.61, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>67.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1043</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.83, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>67.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.84, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>67.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.58, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">68 Feeding route (non‐oral feeding at day 7), by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>68.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.74, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>68.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.27, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>68.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.92, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>68.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.49, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">69 Length of stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [‐6.21, 8.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>69.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [‐6.21, 8.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">70 Length of stay, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4055</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [‐3.28, 5.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>70.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3414</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.99 [‐9.65, 15.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>70.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [‐1.51, 6.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">71 Length of stay by time, to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐1.76, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.55 [‐6.30, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.64 [‐5.13, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐3.56, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐2.68, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>71.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [‐9.40, 12.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">72 Length of stay, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐2.82, 3.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>72.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1644</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.63 [‐8.44, 25.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>72.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.77 [‐18.94, 11.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>72.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.17 [‐4.86, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>72.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.50 [‐2.45, 11.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">73 Headache, on treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.37 [1.55, 3.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>73.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.37 [1.55, 3.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">74 Headache, on treatment, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.34 [1.93, 2.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>74.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.39 [1.59, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>74.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>639</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.91 [1.24, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">75 Headache, on treatment, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4094</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.36 [1.95, 2.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.22 [1.10, 4.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [1.16, 3.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1065</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.57 [1.78, 3.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.27 [1.59, 3.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>75.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [1.64, 3.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">76 Headache, on treatment, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.29 [1.83, 2.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>76.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.37 [1.74, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>76.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.97 [2.14, 4.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>76.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.92, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>76.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.08, 20.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">77 Treatment stopped early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.27, 12.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>77.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.27, 12.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">78 Treatment stopped early, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.49 [0.72, 8.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>78.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.07, 21.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>78.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>637</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.81 [3.46, 13.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">79 Treatment stopped early, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.56 [2.10, 9.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>79.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.05, 22.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>79.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.12 [4.26, 34.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>79.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.42 [4.07, 10.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>79.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.23 [1.63, 52.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>79.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [0.58, 25.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">80 Treatment stopped early, by baseline SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.84 [1.37, 5.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>80.1 &lt; 160 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1687</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.09, 20.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>80.2 160.1 to 180 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.17 [0.17, 27.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>80.3 180.1 to 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>742</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.17, 11.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>80.4 &gt; 200 mmHg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.16 [0.21, 22.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">81 Systolic BP, first treatment measurement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.21 [‐8.58, ‐5.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>81.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.21 [‐8.58, ‐5.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">82 Systolic BP, first treatment measurement, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.01 [‐8.37, ‐5.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>82.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.05 [‐8.51, ‐5.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>82.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.77 [‐10.45, ‐3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">83 Systolic BP, first treatment measurement, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.21 [‐8.57, ‐5.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>83.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.52 [‐14.28, ‐4.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>83.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.92 [‐12.18, ‐3.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>83.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.33 [‐8.07, ‐2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>83.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.17 [‐9.66, ‐4.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>83.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.02 [‐10.66, ‐5.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">84 Diastolic BP, first treatment measurement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.31 [‐4.18, ‐2.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>84.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.31 [‐4.18, ‐2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">85 Diastolic BP, first treatment measurement, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.24 [‐4.10, ‐2.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>85.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.13 [‐4.05, ‐2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>85.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.96 [‐6.36, ‐1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">86 Diastolic BP, first treatment measurement, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.31 [‐4.17, ‐2.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>86.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.31 [‐5.53, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>86.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.5 [‐7.27, ‐1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>86.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.33 [‐3.00, ‐1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>86.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐3.49, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>86.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.68 [‐6.35, ‐3.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">87 Heart rate, first treatment measurement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [1.13, 2.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>87.1 Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [1.13, 2.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">88 Heart rate, first treatment measurement, by stroke type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [1.29, 3.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>88.1 Ischaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.12 [1.14, 3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>88.2 ICH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [0.25, 4.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">89 Heart rate, first treatment measurement, by time to randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.91 [1.02, 2.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>89.1 &lt; 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [‐1.62, 5.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>89.2 6.1 to 12 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐3.16, 2.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>89.3 12.1 to 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [‐0.11, 3.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>89.4 24.1 to 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.44 [1.79, 5.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>89.5 &gt; 36 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [‐0.36, 2.82]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Glyceryl trinitrate (GTN) compared with no GTN for acute stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000398.pub2/references#CD000398-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000398.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD000398-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD000398-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000398-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="ru#CD000398-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000398-note-0008">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000398\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000398\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000398\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000398\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000398\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000398.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000398.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000398.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000398.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000398.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729472834"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000398.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729472837"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000398.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eddbe8d71bd65',t:'MTc0MDcyOTQ3My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 